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ABSTRACT 
Salivary gland stem/progenitor cells are considered a promising solution for 
ameliorating salivary gland damage. mTOR signalling is known to play a role during 
salivary gland atrophy as ligation of the salivary main excretory duct results in the 
activation of mammalian target of rapamycin (mTOR). Cultured mouse and human 
salivary gland stem/progenitor cells in vitro are able to form spherical non-adherent 
clusters named salispheres. As mTOR plays a role during glandular atrophy, 
salispheres were cultured from un-operated, ligated and de-ligated glands. This 
project aimed to understand several factors on the culture of salispheres. Indeed, 
mTOR is inactivated in healthy glands but activated during atrophy. Measuring 
changes in mTOR activity in growing salispheres highlighted the importance of this 
network for salisphere survival, and a potential correlation between glandular atrophy 
and salisphere culture. Rapamycin treatment illustrated the necessity of mTOR for 
growing salispheres, whereas LiCl treatment suggested that GSK-3 inhibition 
stimulated the expansion of salispheres. 
 
Interestingly, injury appeared to alter the growth behaviour of salispheres compared 
to controls. Mainly, salispheres adhere to a surface of the plastic dish and acquire 
fibroblastic-like structures suggesting that signalling alterations might be responsible 
for these changes. The detection of 4e-bp1 and S6 rp expression in salispheres 
suggested that mTOR was responsible for salisphere growth because it is involved 
in protein translation, but it was not responsible for the morphological modification 
post-injury. Changes in the ability of salispheres to adhere to a surface raised two 
questions. First, were morphological alterations mediated by the cytoskeletal 
rearrangement? For this reason, RhoA/ROCK and mTORC2 were investigated, as 
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they are both involved in the cytoskeletal organisation. The use of a ROCK inhibitor 
and torin1 to inhibit ROCK signalling and mTORC2 respectively, suggested that 
ROCK might played a role during atrophy as increased expression of p-FAK and 
CK5 expression in cultured salispheres from ligated glands and treated salispheres 
with ROCK inhibitor.  
 
Second, was the neural input affected by injury and involved in the adherence of 
salispheres? In vivo and in vitro experiments of BoNT/A and neuropeptides were 
included to investigate if these treatments led to similar effects on salispheres as 
injury. However, only in vivo experiments of BoNT/A showed minor similarities, 
implying an unknown complex mechanism is responsible for these changes. 
 
To translate the effect of the in vitro treatments on salivary glands, in vivo 
experiments were included. Injections of treated salispheres with several inhibitors 
were initially applied to normal salivary glands to determine their physiological 
response. Among the different inhibitors, LiCl not only showed significant effects on 
salispheres culture such as preventing salispheres from branching in 
collagen/matrigel culture and supporting their survival, but also showed an effect on 
glandular recovery during de-ligation. This suggested that LiCl might played a role in 
glandular recovery through salispheres.  However, in vivo transplantation of ROCKi 
treated salispheres, which mimicked salispheres from ligated glands, had little or no 
effects on normal salivary glands. However, the activation of mTOR post ROCKi 
injection implies that ROCK signalling might be involved in the atrophic process.  
 
In conclusion, my results show that mTOR an essential factor for salisphere growth 
and survival, and LiCl might be a promising tool for enhancing the recovery of glands 
 16 
post-injury. Finally, the inhibition of RhoA/ROCK could be a factor associated with 
salivary gland atrophy, through ROCK associations with mTOR.   
 17 
ACKNOWLEDGMENTS  
First and foremost, I would like to express my gratitude to my first supervisor Dr. Guy 
Carpenter for his continuous support throughout my doctorate. I am grateful for the 
opportunities you have given me, for your patience, motivation and immense 
knowledge. I could not have asked for a better advisor and mentor. My sincere 
thanks also go to my second supervisor, Prof. Gordon Proctor whose support and 
guidance made it possible for me to carry out my research and made this PhD an 
enriching experience.  
 
I would also like to thank all the members of Salivary Research Laboratory, who 
brought joy and humour to some long days. And a big thank you to Carl Hobbs, 
Mathew Arno and Martti Miamets for their support.  
 
A special thanks to my family. Words cannot express how grateful I am to my mother 
and grandmother for always believing in me and encouraging me to follow my 
dreams. I would also like to thank all of my friends who supported me. In particular 
Hengi and Amy who had more faith in my ability than I did, and encouraged me all 
the way.  
 18 
CONFERENCE PRESENTATIONS  
 
• The role of mTOR for salispheres formation and development. 10th 
European Symposium on Saliva, Netherlands (2014).  
• The effects of ROCK inhibition on salispheres morphology. The 
International Association for Dental Research, Croatia (2014).  
  
 19 
TABLE OF ABBERVIATIONS 
 
ANOVA Analysis of Variance  
AQP5 Aquaporin 5 
AU Artbitrary unit  
BSA Bovine serum albumin  
DMEM-F12 Dulbecco’s Modified Eagle 
Medium:Nutrient Mixture F-12 
DTT Dithiothreitol 
EGF Epidermal growth factor 
FGF Fibroblast growth factor 
LiCl Lithium chloride 
NaCl Sodium chloride 
PBS Phosphate buffered solution 
SGK-1 Glucocorticoid-induced Protein 
Kinase 1 
TBS-T Tris-buffered saline Tween 20 
TK  Tyrosine kinase  














1.1 Salivary glands  
Salivary glands are exocrine glands, which are present in the oral cavity. They are 
important as saliva hydrates and protect the mucosal surfaces, essential for the oral 
processing of food (Delporte and Steinfeld, 2006).  
 
Salivary glands are classified according to size into major and minor glands, or 
according to their type of secretion: serous, mucous or mixed (seromucous). Major 
salivary glands include the parotid, submandibular and sublingual glands (Figure 
1.1). Comparatively, there are approximately 500 to 1000 lobules of minor salivary 




Figure 1.1 Anatomy of the major salivary glands (Dorland et al., 2007). 
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1.1.1 Parotid glands  
The parotid glands are the largest salivary glands in humans. They are located over 
the ramous of the mandible and are surrounded by the sternocleidomastoid muscle. 
Parotid glands contain lymph nodes, facial nerves, the external carotid artery and the 
retromandibular vein. Saliva produced by the parotid glands is transported to the oral 
cavity by the Stensen’s duct. The Stensen’s duct is approximately 7 cm long and 
starts from the interior surface of the parotid gland, and ends at the upper second 
molar tooth (Beale and Madani, 2006). 
 
1.1.2 Submandibular glands  
The submandibular glands fill the major portion of the submandibular triangle, and 
comprise two lobes: the superficial and the deep lobe. Saliva produced by the 
submandibular glands is transported by its main duct (Wharton’s duct), which lies in 
the floor of the mouth (Beale and Madani, 2006).  
 
1.1.3 Sublingual glands 
The sublingual glands are the smallest among the major salivary glands and they lie 
under the mucosa of the floor of the mouth. Sublingual glands comprise 
approximately 20 small ducts, which either drain directly into the floor of the mouth, 
or into the Wharton’s duct (Beale and Madani, 2006).  
 
1.1.4 Minor glands 
Minor salivary glands exist in different locations in the oral cavity and are classified 
according to their location: buccal, labial, palatal, palatoglossal and lingual. 
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Additionally, they are considered mucous glands due to their mucous secretion 
(Berkovitz et al., 2009). 
 
1.2 Mouse salivary glands  
 
Figure 1.2 . Anatomy of major salivary glands in the mouse. Adapted from National 
Institute Health Environmental Health Sciences, 2011. 
 
Salivary glands are composed of parenchyma and stroma. The parenchyma 
comprises the secretory and the ductal units, and the stroma the surrounding 
connective tissue. Within salivary glands are acinar cells, which first produce saliva, 
and ducts, for modifying and transporting saliva into the oral cavity (Figure 1.3)  




Figure 1.3 Microscopic anatomy of salivary glands. A salivary gland is composed of an 
acinar cell, which is surrounded by myoepithelial cells. The acinar cell is connected to an 
intercalated duct, followed by a striated duct and an excretory duct respectively. Adapted 
from Holsinger and Bui, 2006. 
 
1.3.1 Acini 
Acinar cells are classified into serous, mucous and seromucous. Serous acini 
produce a watery, protein-rich secretion, whereas mucous acini produce a viscous-
rich saliva containing mucins (Holsinger and Bui, 2006). Acini are surrounded by 
myoepithelial cells, which facilitates saliva secretion (Humphrey and Williamson, 
2001). Mucous cells produce mucins, which are considered large glycoproteins. The 
viscosity texture of saliva is due to the negative charge of mucins (Tucker, 2007).  
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1.3.2 Ductal system 
Saliva produced by acinar cells is transported to the oral cavity via a ductal system, 
including the intercalated, striated and excretory ducts. The intercalated ducts are 
the first connected ducts to the acinar cells, followed by the striated ducts and the 
excretory ducts. The excretory ducts are the final duct network before saliva drains 
into the oral cavity (Edgar, 1992; Humphrey and Williamson, 2001).  
 
1.4 Histology of mouse salivary glands 
There are several microscopic differences between human and rodent salivary 
glands (Amano et al., 2012). For example, the ductal system in rodent contains 
granular convoluted ducts (GCT), which are located between the intercalated and 
the striated ducts. They produce and release hormones and different growth factors 
such as normal growth factor (NGF) and epidermal growth factor (Gresik, 1994; 
Amano et al., 2012).  
 
Besides the morphological differences between human and rodent salivary glands, 
there is also sexual dimorphism. For example, the weight of a male submandibular 
gland is much higher than the weight of a female submandibular gland (Atkinson et 
al., 1959). Also, the GCT in a male submandibular gland is differentiated by the male 
testosterone hormone, whereas it is rarely developed in female submandibular gland 
(Amano et al., 2012, Gresik, 1994). Moreover, the level of aminotransferase activity 
in male submandibular glands is 10 times higher than in female submandibular 
glands (Hosoi et al., 1978).  
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1.5 Mouse salivary glands embryonic development 
 
Figure 1.4 Salivary gland embryonic development. The stages of salivary gland 
embryonic development. Adapted from Tucker, 2007. 
 
The embryonic development of mouse salivary glands begins at E11.5 where a 
thickening of the epithelium next to the tongue is observed; this stage is called the 
pre-bud stage (Figure 1.4). The process of thickening of the epithelium continues to 
the underlying mesenchyme producing a bud connected to the oral surface by a duct 
at E12.5. Then, this bud proceeds to the second, pseudoglandular stage, where the 
bud branches to produce a cluster of buds (Tucker, 2007).  
 
Next, the process of branching morphogenesis begins at E13.5, where the 
epithelium produces four to five buds and a multi-lobed gland by E14.5. The ducts of 
salivary glands undergo cavitation at E15.5 and develop a lumen (Tucker, 2007). 
Apoptosis plays a role during the development of the lumen in the cavitation stage 
and occurs specifically in the ducts, and relies on caspase-3 as a mediator of the 
apoptotic pathway (Jaskoll and Melnick, 1999, Tucker, 2007). At stage E17 the 
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terminal bud stage is reached and a well–developed lumen is observed (Figure 1.4) 
(Tucker, 2007, Melnick and Jaskoll, 2000).  
 
1.6 Factors affecting branching morphogenesis 
The process of branching morphogenesis requires an interaction between the 
epithelium and the mesenchyme, where the mesenchyme controls the signals for 
this interaction (Tucker, 2007). There are several genes responsible for regulating 
each stage of branching morphogenesis. For example, Fgf10 expression occurs 
during the pre-bud stage and the mutation of this gene prohibits the formation of 
salivary glands (Tucker, 2007; Ohuchi et al., 2000; Patel et al., 2006). Likewise, the 
Pitx2 knockout mouse prevents salivary gland formation at E17.5 (Tucker, 2007, 
Szeto et al., 1999). 
 
The branching process is regulated by the extracellular matrix (Rosenthal et al.), 
which is a continuous sheet of the basement membrane and separates the 
epithelium from the mesenchyme. There are several proteins that are present in the 
ECM such as glycosaminoglycans, fibronectin, collagen and integrins; each 
component plays a role in branching morphogenesis (Tucker, 2007). For instance, 
the inhibition of fibronectin blocks cleft formation (Sakai et al., 2003).  
 
1.7 Saliva 
1.7.1 Composition  
Saliva contains many proteins, which are mostly produced by the salivary glands. 
These proteins differ among the glands, but some are produced by all glands, such 
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as immunoglobulin A, which is the main antibody of saliva. Additionally, salivary 
glands are rich with amylase, which thought to be important for post-mastication and 
clearing the mouth from food. In addition, proline-rich proteins (PRPs), comprised 
mostly of basic PRPs, are only present in the parotid glands, unlike the acidic PRPs 
that are present in both parotid and submandibular glands. Likewise, mucins are 
produced by the submandibular and sublingual glands, but are not produced by the 
parotid gland due to their serous secretion (Carpenter, 2013).  
 
1.7.2 Functions 
Saliva plays various roles in oral health such as digestion, lubrication and buffering, 
and possesses antimicrobial and antiviral properties (Carpenter, 2013; Amerongen 
and Veerman, 2002). Functions of saliva are dependent on the surface, that is teeth 
or mucosa, and can serve mutual or exclusive functions or both. The diagram below 
summarizes the functions of saliva according to the surface (Figure 1.5) (Carpenter, 





Figure 1.5 A summary of saliva functions depending on the surface [Adapted from 
(Carpenter, 2013)]. 
 
1.7.3 Saliva secretion  
 
Figure 1.6 A simple model of salivary gland secretion [Adapted from (Catalan et al., 
2009)]. 
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In humans, most adult unstimulated salivary flow is around 0.5 mL/min-1, while 
during sleep the salivary flow is around 0.1 mL/min-1 (Carpenter, 2013). The process 
of salivary secretion is summarized in two stages. First, an isotonic plasma-like 
primary secretion is produced, which is rich in sodium chloride. This primary saliva is 
modified while passing through the ducts, where the high levels of sodium chloride 
are reabsorbed and potassium is released (Figure 1.6) (Catalan et al., 2009; Melvin 
et al., 2005), producing a final hypotonic saliva (Humphrey and Williamson, 2001).  
 
1.8 Autonomic nerve and salivary function 
The secretion of saliva is nerve mediated; although, in some animals such as in 
sheep spontaneous nerve-independent saliva secretion. The parasympathetic 
nerves influence saliva secretion primarily by responding to afferent stimuli such as 
taste (Proctor and Carpenter, 2007). Parasympathetic stimulation is partly mediated 
by acetylcholine, while the sympathetic stimulation by noradrenaline (Garrett, 1987). 
The role of neural regulation of salivary secretion is explained further in Chapter 5. 
 
1.9 Irreversible damage of salivary glands 
There are several conditions that cause salivary gland hypofunction leading to oral 
dryness, a condition termed xerostomia, whereby saliva volume is decreased and 
saliva composition is altered (Nederfors, 2000; Saleh et al., 2015). Xerostomia 
causes difficulties in swallowing, chewing, impairment in taste, and increase dental 
caries (Sreebny and Valdini, 1987). These symptoms cause discomfort to patient 
and affect their quality of life. Some drugs are associated with salivary glands 
hypofunction, such as anti-HIV medication (Navazesh et al., 2009). In addition, 
systemic disorders such as Sjögren’s syndrome and even radiotherapy treatment is 
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associated with xerostomia (Eisbruch et al., 200; Vissink et al., 2003;  Saleh et al., 
2015).  
 
Radiotherapy is a common treatment for head and neck cancer. However, this 
treatment is one of the most common causes of salivary gland hypofunction (Deasy 
et al., 2010). Salivary glands are particularly susceptible to radiotherapy and undergo 
degeneration due to irradiation. However, the success of radiotherapy is often 
measured by the dose of radiation and the response of the patient to the treatment 
(Lin et al., 2008; Coppes et al., 2009; Dirix et al., 2008). For example, in animal 
studies radiation affects saliva flow rate, although the late effects vary among the 
parotid and the submandibular glands (Coppes et al., 2002).  
 
In contrast to salivary gland atrophy, there are several conditions that contribute to 
hypersalivation. This condition usually is associated with neurological disorders such 
as Parkinson’s disease and cerebral palsy in children, resulting in severe drooling 
(Seifert, 1987; Ellies et al., 2000).  
 
1.10  Salivary gland regeneration 
In normal conditions, salivary gland cells undergo autologous cell division for tissue 
homeostasis and damage repair. However, in the case of injury, normal autologous 
cell division is insufficient for maintaining tissue function and repairing the damage. 
Hence, progenitor cells are thought to be important for salivary glands regeneration. 
There are two common models used for studying regeneration, which are described 
below (Okumura et al., 2012).  
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1.10.1 Ligation/de-ligation  
Ligation is a method used to understand the importance of salivary gland progenitor 
cells and the origin of new cells undergoing regeneration (Okumura et al., 2003; 
Cotroneo et al., 2010). Ligation of the main excretory duct induces apoptosis and 
causes the depletion of acinar cells, followed by ductal cell proliferation (Sato et al., 
2007). While de-ligation has shown the ability of the salivary gland to recover and 
produce mature acinar cells (Takahashi et al., 1998). De-ligation causes the 
upregulation of the neonatal protein SMG-B and the recovery of Aquaporin 5 (AQP-
5) which is usually expressed in the intercalated ducts of mature glands and in the 
acinar cells during the neonatal development (Cotroneo et al., 2010). 
 
1.10.2 Radiation  
Radiation is another model for studying regeneration and characterizing progenitor 
cells of salivary glands. Irradiation of salivary glands has either acute or chronic 
effects on salivary function, where the dose of radiation plays a role in the gland 
recovery. The use of radiation as a model helps to determine the number of 
remaining progenitor cells post-radiation, therefore assessing the regenerative 
capacity (Pringle et al., 2013). In addition, radiation studies help to elucidate the role 
of primitive cell transplantation into damaged gland tissue during regeneration (Feng 
et al., 2009). Although radiation is a well-used model, for the purpose of this thesis 
the ligation/de-ligation model was used. 
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1.11 Salivary gland stem/progenitor cells 
Stem cells are defined as undifferentiated cells that are capable of differentiating into 
any specific tissue type and have a high degree of self-renewal. They play a role in 
homeostasis and are involved in tissue regeneration of many organs (Bishop et al., 
2002; Korbling and Estrov, 2003). Oral tissue is believed to have a high number of 
stem cells (Egusa et al., 2012); although, a true stem cell has yet to be found in 
salivary glands. A true stem cell is characterized by the unlimited self-renewal and is 
considered the precursor of progenitor cells. Due to the lack of universal markers it is 
difficult to identify and purify stem cells (Kimoto et al., 2008). Label-retaining studies 
explain the process of asymmetric division of stem cells in tissue development and 
regeneration. A stem cell can produce two daughter cells: one stem cell and one 
transient cell (Kimoto et al., 2008; Coppes et al., 2009).  
 
Progenitor cells are more lineage committed and organ-specific. They also have less 
capacity to self-renew as they become more differentiated to produce one cell type. 
Importantly, a stem cell might produce a differentiated daughter cell, which can 
undergo further cell division and produce progenitor cells. This process results in the 
tissue homeostasis, through their differentiation and maintenance of the 
stem/progenitor pool (Lombaert and Hoffman, 2010; Lombaert et al., 2011; Pringle et 
al., 2013).  
 
A true stem cell is able to produce all type of cells of specific organ such as the 
mammary gland. However, the identification of a single stem cell that can produce 
the whole epithelial cell types is still unknown (Lombaert et al., 2011, Stingl et al., 
2006).  
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1.12  Localization of salivary gland stem/progenitor cells 
 
 
Figure 1.7 The location of stem and progenitor cells in salivary glands. It has been 
suggested that primitive cells are localized in the main excretory and striated ducts, while the 
progenitor cells are localized in the striated and intercalated ducts. This stem cell pool is 
believed to be responsible for replacing and producing mature acinar cells and duct cells 
[Adapted from (Pringle et al., 2013)]. 
 
Label retaining cells (LRCs) studies have localized the stem/progenitor cells in the 
ductal compartment (Denny et al., 1993; Man et al., 2001; Kimoto et al., 2008). In 
male rats, cell labelling suggested the differentiation of intercalated ducts and 
striated ducts into granular ducts (Denny et al., 1993). The pattern of labelled cells 
changes with time suggesting that cells move from the intercalated ducts to the 
granular ducts or striated ducts as well as to the acini, resulting in cell differentiation 
(Figure 1.7) (Zajicek et al., 1985). However, the number of labelled intercalated ducts 
 35 
decreases with time. These intercalated cells have shown to differentiate into both 
acinar and granular duct cells (Man et al., 2001). The use of LRCs helped in 
identifying a small pool of stem/progenitor cells of salivary glands. Ligation/de-
ligation experiments on rat submandibular glands illustrated the existence of LRCs 
during regeneration (Kimoto et al., 2008). Although it is believed that irradiation 
sterilizes the residing progenitor cells, previous studies have shown that LRCs in 
salivary glands are maintained post-radiation and these cells are considered 
progenitor cells (Konings et al., 2005; Chibly et al., 2014).  
 
Human and mouse salivary gland stem/progenitor cells are thought to be located in 
the ductal compartment (Sato et al., 2007; Lombaert and Hoffman, 2010). Previous 
work suggested that stem cells are responsible for supplying the progenitor cell pool 
and are also involved in replenishing duct and acinar cells (Pringle et al., 2013).  
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1.13  Salivary gland stem/progenitor cell expressing markers 
The identification of stem/progenitor cells by specific protein markers is essential for 
their phenotypic validation. However, isolating stem/progenitor cells from solid 
tissues, such as salivary glands, requires dispersing tissue into cell suspension by 
mechanical forces and enzymatic digestion (Coppes and Stokman, 2011).  
 
There are different markers that are important for assessing salivary gland 
regeneration such as CD49f, Sca-1, c-kit and Ascl3. The expression of stem-
associated markers in the ducts indicates the presence of these progenitor cells 
(Rugel-Stahl et al., 2012; Nanduri et al., 2013).  
	  
it is one of the important stem cell markers (Edling and Hallberg, 2007). Studies on 
c-kit expressing cells have shown the capacity of these cells to regenerate and 
restore salivary gland function (Lombaert et al., 2011). For example, transplanting c-
it+ cells into an irradiated gland resulted in the production of differentiated acinar cells 
and progenitor cells (Nanduri et al., 2013).  
 
These stem cell markers are used to assess the in vitro differentiation and in vivo 
function (Pringle et al., 2013). For instance, c-kit expressing cells in mouse and 
human have been tested for in vitro differentiation, but only mouse expressing c-kit 
have been tested for the in vivo function (Lombaert et al., 2008a; Feng et al., 2009, 
Nanduri et al., 2011).  
 
In addition, the transcription factor Ascl3 was also established as a marker for 
progenitor cells in salivary glands. Ascl3 expressing cells are localized in all mature 
ducts and only represent a subset of progenitor cell population (Bullard et al., 2008). 
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The identification of these markers is important to identify the precursor of these 
cells, which are involved in maintenance and regeneration.  
 
1.14  Salivary gland stem/progenitor cells and regeneration  
The irreversible damage of salivary gland function by irradiation is associated with 
the sterilization of primitive glandular stem cells (Konings et al., 2005). Salivary 
glands are highly radiosensitive as severe loss of saliva production is observed by 
phase 1 and phase 2 (Coppes et al., 2001). A potential treatment is bone-marrow 
derived cell (BMC) transplantation to regenerate damaged salivary glands (Lombaert 
et al., 2006a; Sumita et al., 2011). However, the transplantation of salivary gland 
stem/progenitor cells may be more beneficial, because in vivo studies have shown a 
native supply of stem/progenitor cells in salivary glands (Denny et al.,1993; Man et 
al., 2001; Lombaert et al., 2008a).  
 
Additionally, mouse salivary gland Sca-1+/c-kit+ expressing cells are able to 
differentiate into pancreas and liver lineages (Hisatomi et al., 2004). The use of stem 
cell markers has demonstrated that as few as 300 c-kit expressing cells can recover 
salivary gland function (Lombaert et al., 2008a; Nanduri et al., 2011). In addition, a 
functional recovery of damaged salivary glands was observed by transplanting 
around 5,000 of CD29, CD49f or CD133 expressing cells (Nanduri et al., 2011). 
Parasympathetic nerves are also important for regeneration, since the 
parasympathetic nerves are essential for maintaining K5+ epithelial progenitor cells 
during development (Knox et al., 2010). In the context of regeneration, a reduction of 
parasympathetic innervation resulted in a loss of acinar cells. This suggests that 
maintaining parasympathetic innervation after injury is important for epithelial tissue 
regeneration (Knox et al., 2013).  
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Although no in vivo functional analysis has tested human tissue, there are several 
studies that have shown the ability of human primary salivary gland cells to 
differentiate in vitro. Either using a hydrogel culture system or a matrigel-coated 
matrix, primary human salivary gland cells displayed some aspects of differentiation 
(Joraku et al., 2007; Feng et al., 2009; Maria et al., 2011, Pradhan-Bhatt et al., 
2013). A three-dimensional culture system has also been used to determine their 
ability to grow and differentiate into a functional salivary acinar-like structure (Feng et 
al., 2009; Pradhan-Bhatt et al., 2013).  
 
Recently, the xenotransplantation model has also indicated the therapeutic potential 
and capacity of human salivary gland stem/progenitor cells to restore salivary 
function in vivo (Pringle et al., 2016). Although, it is important to understand and 
consider the biological differences between humans and rodents and their responses 
to radiation (Lombaert et al., 2017). 
 
1.15  Salispheres 
The isolation and culture of salivary gland stem/progenitor cells typically involves 
using a monolayer or non-adherent culture system (Pringle et al., 2013). A 
monolayer culture system was mostly performed from rat salivary glands, while a 
non-adherent culture system was performed from mouse salivary glands (Kishi et al., 
2006; Lombaert et al., 2008a; Nanduri et al., 2011; Neumann et al., 2012).  
 
Advances studies using glandular stem cells, for example, cells derived from the 
mammary gland have applied the non-adherent technique (Reynolds and Weiss, 
1992; Liao et al., 2007). This method is useful for driving a functional group of 
progenitor cells (Pringle et al., 2013). Likewise, non-adherent culture of salivary 
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gland stem/progenitor cells was developed successfully (Lombaert et al., 2008a; 
Nanduri et al., 2011; Pringle et al., 2011).  
 
Isolation and culture of salivary gland stem/progenitor cells in vitro grow in spherical, 
non-adherent clusters named as salispheres (Lombaert et al., 2008a; Coppes et al., 
2009; Nanduri et al., 2011). This process initially requires dispersing the tissue by 
enzymatic digestion and mechanical forces. This results in a mixed population of 
dead and living cells where dead cells are separated and stem/progenitor cells are 
enriched during the intermediate step of cell culture (Coppes and Stokman, 2011). 
 
These spheres appear around day two or three after culturing in serum-free medium 
containing growth nutrients. Salisphere formation is similar for both human and 
mouse cells (Lombaert et al., 2008a; Feng et al., 2009). Interestingly, salispheres 
from human and mice express c-kit, and their development into a spherical formation 
allows them to differentiate in vitro (Sato et al., 2007; Pringle et al., 2013).  
 
1.16  Role of signalling pathways in salivary gland regeneration  
Growth factors and signalling networks play an important role in salivary gland 
stem/progenitor pool regeneration (Lombaert et el., 2008b; Silver et al., 2010). 
Several studies have been performed to understand the role of signalling networks 
on salivary gland regeneration such as Wnt signaling (Hai et al., 2010).  
 
Studies on systemic stimulation of growth factors have shown a role in rescuing 
salivary glands against irradiation-induced damage. For example, intravenous 
injection of insulin-like growth factor 1 (IGF-1) replenished apoptotic cells caused by 
radiation and preserved salivary gland function via the activation of Akt (Limesand et 
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al., 2009). In addition, keratinocyte growth factor (KGF) also increases salivary gland 
progenitor cell population and has a role in improving salivary gland function post-
radiation (Lombaert et al., 2008b). Moreover, a study by Xiao and colleagues (2013) 
suggests that aldehyde dehydrogenase-3 activator (ALDH) may protect acinar cells 
against radiation and increase saliva production.  
 
Gene expression analysis showed that glial cell line-derived neurotrophic factor 
(GDNF) is upregulated post-radiation in mice submandibular glands. The 
administration of GDNF improved saliva production and enrichment of functional 
acinar cells in irradiated glands (Xiao et al., 2014).  
 
Several studies have also assessed the role of protective intrinsic signalling 
pathways in salivary glands. For instance, the activation of hedgehog (Hh) exhibited 
a role in protecting salivary gland stem/progenitor cell and parasympathetic 
innervation against irradiation (Hai et al., 2014).   
 
Wnt signalling is activated in stem/progenitor cells compartment, which decreases 
parallel to age of mice. However, a significant upregulation of Wnt activity 
accompanied with Hh signalling occurs as a consequence of main duct ligation. 
 
 This suggests that the activation of Wnt and Hh are responsible for the molecular 
control of the regenerative process (Hai et al., 2010). In previous studies, the 
concurrent activation of Wnt signalling protected salivary gland function against a 
single dose of irradiation and the concurrent activation of the Wnt pathway inhibited 
apoptosis, and protected the stem/progenitor pool (Hai et al., 2012). Wnt also plays a 
role in the long-term expansion of salivary gland stem/progenitor cells; for example, 
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the transplantation of Wnt-induced stem/progenitor cells into a damaged gland 
resulted in the recovery of tissue homeostasis (Maimets et al., 2016). 
 
The mammalian target of rapamycin (mTOR) is another important pathway for cell 
growth and differentiation. It is considered an important regulator of skeletal muscle 
hypertrophy and atrophy (Bodine et al., 2001). In normal adult salivary glands, 
mTOR is inactive; however, it has been demonstrated that mTOR may play a role 
during salivary gland injury as it protects a subpopulation of acinar cells (Silver et al., 
2010). The administration of rapamycin which is an inhibitor of mTOR can delay 
ligation-induced atrophy. The full inhibition of mTOR suggested that rapamycin 
prevents the degradation of secretory glycoproteins by preserving the mucin content 
post-treatment (Bozorgi et al., 2014). Since mTOR is an important signalling network 
for cell growth, and most importantly, is associated with salivary gland atrophy, the 
reminder of this chapter will focus on the characteristics of mTOR.  
 
1.17  mTOR  
mTOR plays a significant role in growth and cell proliferation (Sarbassov et al., 
2005). The TOR protein is a serine threonine kinase, which targets the compound 
rapamycin. It interacts with several proteins to produce two main complexes: mTOR 




1.17.1 mTOR general structure  
 
Figure 1.8 mTOR domain structure. 
 
mTOR is composed of 2549 amino and comprises several conserved domains. The 
first 1200 amino acids are tandem HEAT repeats, which stands for huningtin, 
elongation factor 3, a subunit of PP 2A and TOR (Figure 1.8) (Gingras et al., 2001b). 
A FAT (FRAP, ATM, TRRAP) domain is located after the HEAT repeats and binds to 
the FKPB12-rapamycin binding (FRB) domain (Brown et al., 1994). A kinase domain 
(KB), a repressor domain and FAT carboxyl-terminal (FATC) domain are located 
after the FRB domain and regulate mTOR activity (Perry and Kleckner, 2003).   
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1.17.2 mTORC1  
 
Figure 1.9 The main components of mTORC1. 
 
mTORC1 consists of five components: the catalytic subunit which is mTOR, a 
regulatory-associated protein of mTOR (Raptor), mammalian lethal which hSec13 
protein 8 (mLST8 or GβL), proline rich AKT substrate 40 kDa (PRAS40) and DEP-
domain-containing mTOR-interacting protein (Deptor) (Laplante and Sabatini, 2009). 
There are several upstream signals that regulate and control mTORC1 activity such 





Figure 1.10 The main components of mTORC2. 
 
The second complex of mTOR is composed of six components, where it shares 
some of mTORC1 proteins such as Deptor and mLST8. It also contains rapamycin 
insensitive companion of mTOR (Rictor), mammalian stress-activated protein kinase 
interacting protein (mSIN1) and protein observed with Rictor-1 (Protor-1) (Laplante 
and Sabatini, 2009).  
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1.17.4 mTOR mechanism of action 
 
Figure 1.11 A schematic diagram for mTOR signalling pathway. Several factors play a 
role in the activation of mTOR signalling such as energy levels, amino acids, Wnt signaling 
and growth factors. The activation of Wnt signalling by the binding of Wnt protein to the 
frizzled receptor leads to the phosphorylation of GSK-3 by Dishevelld and the activation of 
mTOR. Growth factors also play a role in mTOR activation through Akt, which phosphorylates 
TSC2 subsequently activating mTOR via Rheb. As a result of mTOR activation, the main 
substrates of mTOR, 4e-bp1 and S6K, are phosphorylated. Various processes are regulated 
by mTOR such as protein synthesis and autophagy. 
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The mechanisms of action of the two complexes of mTOR are different in terms of 
their upstream regulators and downstream effectors. In the case of mTORC1, there 
are several upstream regulators, including growth factors, energy levels, stress, 
amino acids and Wnt signalling (Inoki et al., 2006; Sengupta et al., 2010; Laplante 
and Sabatini, 2012b; Jewell et al., 2013). The heterodimer, tuberous sclerosis 1 or 
hamaratin (TSC1) and tuberin (TSC2), cooperate in mTORC1 activation (Inoki et al., 
2003b). The activation of mTOR by growth factors and Wnt signals subsequently 
phosphorylates TSC2, which in turn inhibits Ras homolog enriched in brain Rheb 
and thus activates mTOR (Figure 1.11) (Inoki et al., 2006; Sengupta et al., 2010). 
Rheb is a small GTPase which has been shown to be regulated by TSC2 and 
involves in mTOR activation. mTORC2 regulates several processes such as protein 
synthesis, lipid synthesis and autophagy via phosphorylation of two main substrates, 
4e-bp1 and S6 kinase (S6K) (Jung et al., 2010; Laplante and Sabatini, 2012b; Lloyd, 
2013). The expression of 4e-bp1 and S6K subsequently leads to the phosphorylation 
of eIF4 and S6 respectively; thus, regulating cell growth and protein synthesis 
(Jastrzebski et al., 2007; Magnuson et al., 2012). There are three isoforms of 4e-bp1 
phosphorylation, which include α (hypo-phosphorylated), β (phosphorylated) and γ 
(hyper-phosphorylated). The function of eIF4 is dependent on the degree of 4e-bp1 
phosphorylation (Beretta et al., 1996; Gingras et al., 2001a; Silver et al., 2010).  
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Although mTORC2 is not as well understood as mTORC1, mTORC2 it regulates 
several elements such as Akt which is involved in apoptosis, metabolism and 
proliferation. mTORC2 also regulates glucocorticoid-induced protein kinase 1 
(GSK1), which is responsible of ion transport and growth. Also, protein kinase C-α 
(PKC-α), which regulates cell shape (Garcia-Martinez and Alessi, 2008; Laplante 
and Sabatini, 2012b).  
1.17.5 Rapamycin  
 
Figure 1.12 Rapamycin cite of action on mTORC1 
 
Rapamycin is an anti-fungal molecule, which was isolated from the soil in the 
Eastern Islands in the 1970s. It is produced by the bacterial species Streptomyces 
hygroscopicus (Vezina et al., 1975). Rapamycin is also considered a potent 
molecule for inhibiting cell proliferation and is a valuable molecule for studying cell 
growth (Laplante and Sabatini, 2012a). The ability of rapamycin to bind to the FRB 
domain results in the inhibition of mTORC1 but not mTORC2 (Jacinto et al., 2004; 
Ballou and Lin, 2008). Rapamycin is also associated with autophagy and 
characterized by an anti-proliferative property, which could benefit patients with 
cancer (Hidalgo and Rowinsky, 2000; Cai and Yan, 2013).  
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1.18  Aim 
The aim of this project was to explore factors affecting salispheres culture during 
normal development and during injury. Because the mTOR pathway is an essential 
signalling network responsible for cell cycle progression and it is activated in atrophic 
salivary glands, I focused on the role of mTOR in the development of salispheres 
from normal and injured glands. My aim was to investigate if mTOR is fundamental 
for salispheres survival. I also assessed the morphological differences and mTOR 
status between cultured salispheres from normal and injured glands, to determine 
whether mTOR is associated with injurious morphological modifications. In addition, I 
investigated possible factors associated with injury such as cytoskeletal 
rearrangements and neural influences. In vivo transplantation of treated salispheres 
with the different inhibitors into mouse salivary gland will assist in translating if the 













2 MATERIALS AND METHODS 
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2.1 Animals  
Adult female ICR mice were obtained from Charles River Laboratories (Margate, UK) 
weighing 25-30 g upon arrival. Mice were housed in groups of four, supplied with 
food and water ad libitum. A 12 h light-dark cycle was maintained at constant 
temperature of 20-22°C, and environmental enrichments (tunnel and nesting 
material) were provided in each cage. Animals were kept for one week under clean 
conditions to allow them to acclimatize to their new environment before beginning 
any experimental procedure. The mice were terminally anesthetized by an overdose 
injection of pentobarbitone. Submandibular glands were dissected and all 
procedures were carried out under aseptic conditions. All animal procedures were 
conducted under the UK Home Office Animal (Scientific Procedures) Act 1986.  
 
2.2  Salivary gland stem/progenitor cell isolation and culture  
Salivary gland stem/progenitor cells were isolated and cultured according to an 
established protocol (Pringle et al., 2011).  
 
Dissected submandibular glands were chopped for around 3 minutes. The 
homogenate was digested for 20 minutes using a mixture of collagenase II (23 
mg/ml), hyaluronidase (40 mg/ml) and CaCl2 (50 mM) for 80 mg gland weight in 5% 
BSA HBSS buffer. Then, the homogenate was mixed by pipetting and incubated for 
20 minutes. The digestion and mixing steps were repeated with gentle mechanical 
movement at 37°C. Next the homogenate was washed twice with 5% BSA HBSS 
buffer. Following washing, the homogenate was filtered by 100 µm cell strainer then 
through a 50 µm pore size filters and a 25G needle. Pelleted cells were re-
suspended in SC medium which contains DMEM/F-12, penicillin/streptomycin (1%), 
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glutamax (1%), EGF (20 ng/ml), FGF (20 ng/ml), N2 supplement (1/100), insulin (10 
µg/ml) and dexamethasone (1 µM) then plated in non-coated 12-well dishes. All 
pelleting steps were performed at 400 g for 5 minutes.  
 
All reagents were purchased from Sigma-Aldrich (Dorset, UK), except HBSS, 
glutamax, collagenase II and N2 supplement, which were purchased from GIBCO 
(Thermo Fisher Scientific Inc., Carlsbad, CA).  
 
2.3 Cell/salispheres counting  
For counting, the Bio-Rad TC20 automated cell counter (Bio-Rad Laboratories Ltd, 
Hertfordshire, UK) was used for counting cells prior culture (at day 0). The cell pellet 
was re-suspended in 1 ml of SC medium and 10 µl of cells were mixed with 10 µl of 
trypan blue (Thermo Fisher Scientific Inc., Carlsbad, CA) and loaded onto a slide for 
reading. The number of salispheres was determined by counting 10 µl, then the 
number of salispheres in 1 ml volume of media was calculated according to the 
equation below:  
 
Total number of salispheres / ml = number of salispheres x 1000 µl of media / 
10 µl 
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2.4 Imaging  
Salispheres were imaged at different magnification including 10x, 20x and 40x and at 
different time-points depending on the experimental design by the phase-contrast 
microscopy (Olympus Essex, UK). 
 
2.5 Size of salispheres  
The size of salispheres was determined by measuring the area of 5-10 salispheres 
at 40x magnification and averaged by Image J software version 1.46 from each 
individual experiment (NH Maryland, MD, USA). 
 
2.6 Salispheres collection 
Salispheres were collected for protein analysis by pelleting the spheres at 3000 rpm 
for 5 minutes. The pellet was washed with PBS and lysed by RIPA buffer and stored 
at -20°C for further analysis.  
 
2.7 Gel electrophoresis and Immunoblotting  
Samples were processed for SDS-PAGE gel electrophoresis under reducing 
conditions. The samples were prepared with 1/4 LDS and 1/10 DTT of total sample 
volume. Protein separation was carried out either by loading equal protein 
concentrations or equal volumes of sample into NUPAGE®  4-12% Bris-Tris gel (Life 
technologies, Paisley, UK) for 32 minutes at 200 V and 125 mA. The reason behind 
using equal volumes of cells/salispheres homogenates rather than equal protein 
concentrations was to maximize concentration of loaded proteins in all lanes. Co-
staining of blots with β-actin or GAPDH allowed normalization between lanes. Gels 
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were either used for Periodic Acid Schiff’s staining and Coomassie Brilliant Blue 
staining, which are explained below in sections 2.15 and 2.16, or proceeded to the 
electroblotting step.  
 
Proteins were electroblotted onto 0.45 µm nitrocellulose membranes (Aderman and 
Co., Kingston-Upon-Thames, UK) for one hour at 30 V and 200 mA. Transferred 
proteins on the nitrocellulose membranes were then processed for immunoprobing. 
The membrane was blocked with Tris-buffered saline tween 20 (TBST) (20 mM 
TRIS, 150 mM NaCl, 0.1 % Tween-20, PH 7.6) for one hour followed by either an 
hour incubation or overnight incubation with primary antibody. Next, the membrane 
was washed three times for 5 minutes each with TBST. The membrane was 
incubated for two hours with secondary antibody and was washed 5 minutes, three 
times for 5 minutes with TBST, three times with TBST and visualized using the 
ChemiDoc imaging system (Bio-Rad Laboratories, Hertfordshire, UK) after adding 
the ECL substrate (Bio-Rad Laboratories Ltd, Hertfordshire, UK). Equal volumes of 
the reagents were mixed and applied to the membrane for visualizing protein 
expression. All of the running buffers, transfer and gels were purchased from Novex 
(Invitrogen, Carlsbad, CA). The function of ChemiDoc imaging system is mainly 
based on measuring the band intensities of protein of interest where the band 
intensity increases parallel to time of exposure (Figure 2.1). The pattern of protein 
expression is similar regardless if the band intensity was measured at 5 seconds or 
60 seconds (Figure 2.2). However, all immunoblots have been chosen before 40 
seconds as the blots become saturated after 40 seconds. Appendix B is a 
supplementary of five concentrations of submandibular gland tissue homogenates 
(Table 2.2) which have been probed with β-actin at different time-points to illustrate 
the principle of ChemiDoc system. 
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2.8 Antibodies 
Antibodies Abbreviation Molecular 
weight (kDa) 
Dilution Company 
Phospho 4ebp1  
p-4e-bp1 



























     
 
Table 2.1 Primary antibodies used in all chapters. 
 
As 4e-bp1 expression ranges between hypophosphorylated to hyperphosphorylated, 
in these series of experiments, the hyperphosphorylated form was indicated as the 
active 4e-bp1 and the hypophosphorylated form was indicated as the inactive 4e-
bp1.  
 
All immunoblots were probed overnight with primary antibodies expect for two hours 
with β-actin. Goat anti-mouse HRP or anti-rabbit HRP antibodies were used as 
secondary antibodies for two hours at room temperature (Dako Ltd, Ely, UK), 
followed by chemiluminescent detection.  
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2.9 Densitometry  
Band intensities of protein of interest were quantified by the Lab Image software 
(Bio-Rad Laboratories, Hertfordshire, UK). Acquired values were normalized to the 
values of β-actin.  
 
2.10  MTS viability assay  
The MTS assay was processed by adding 20 µl of the MTS reagent (Promega, 
Southampton, UK) to 100 µl of cells or salispheres in 96 wells plate according to the 
manufacturer protocol. Following 3 hours of incubation, the proliferation was 
determined at an absorbance of 490 nm by the Bio-Rad microplate reader (Bio-Rad, 
Hertfordshire, UK). To insure equal density, cells were cultured at day 0 in 96 wells 
and processed for MTS assay depending on the experimental design.  
 
2.11 Organoid formation assay 
To examine the ability of salispheres to form ductal-acinar like structure, salispheres 
were cultured in collagen/matrigel matrix according to the Nanduri et al. (2014) 
protocol. Briefly, salispheres were collected at day 4 of culture and pelleted at 400 g 
for 5 minutes. The pellet was resuspended at a ratio of 40 µl of collagen in DMEM/F-
12. 60 µl of matrigel was added to the mixture and the total volume of 100 µl was 
plated into a flat-bottom 96-well plate. The collagen/matrigel matrix was then 
incubated at 37°C for approximately 15 minutes to allow the matrix to solidify. SC 
medium containing 10% of fetal calf serum (FCS) was added. Organoids were 
observed and imaged every two days of culture.  
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2.12 Tissue collection 
For tissue analysis, the submandibular glands were dissected at the end of the 
experiments and divided into two pieces. One piece was homogenized for 
biochemical analysis and the second piece was fixed in 4% formalin for histological 
analysis. 
 
2.13 Gland homogenization  
10 mg of tissue was homogenized in a homogenizing buffer solution to for a 5% 
(w/v) homogenate by the MP FastPrep-24 homogenizer (MP Biomedicals, LLC, 
USA). The homogenizing buffer solution consists of 1% TritonX-100, 1 mM EDTA 
and 1% v/v dilution of protease inhibitor cocktail set 1 (Merck Chemicals Ltd, 
Nottingham, UK). The volume of homogenizing buffer solution used was calculated 
as below:  
 
Gland weight x 19 = volume of homogenizing buffer required 
 
The samples were centrifuged and supernatants were collected for biochemical 
analysis.  
 
2.14  Protein concentration quantification  
Protein concentrations of submandibular gland tissue homogenates were measured 
in 96-well plates using the BCA assay (Thermo Scientific, IL, USA), according to the 
manufacturers’ instructions. A dilution of 1:100 of the homogenates was used and 
the results were compared to a standard curve of BSA.  
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2.15  Periodic Acid Schiff’s staining  
A Periodic Acid Schiff’s staining (PAS staining) protocol was used to determine and 
evaluate glycoproteins. After gel electrophoresis, the gel was fixed in 25% methanol 
and 10% glacial acetic acid for one hour. Then, the gel was washed in water for 20 
minutes followed by incubation for 15 minutes in 2% (w/v) periodic acid. The gel was 
washed with distilled water and incubated with Schiff’s reagent in the dark for one 
hour until pink bands are developed. 
 
2.16  Coomassie Brilliant Blue staining  
After electrophoresis, gels could be stained with 25 ml of Coomassie Brilliant Blue R-
250 solution plus 10 ml of 10% acetic acid solution for 20 minutes. The gels were 
then washed with 10% acetic acid only prior to imaging the gels.  
 
2.17  Tissue sections and histochemical staining 
Tissue samples were fixed overnight in 4% formalin and dehydrated in an ascending 
alcohol series before embedding in paraffin. Sections were cut using the microtome 
at a thickness of 5 µm and mounted on super-frost plus coated slides.  
 
Slides were incubated on a heat block at 60°C for one hour followed by de-waxing, 
whereby the slides were incubated twice in xylene; a first incubation for 5 minutes 
and a second for 10 minutes. Next, the slides underwent 3 incubation steps (3 
minutes each) in 100% industrial methylated spirit followed by washing under 
running water.  
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2.18  Haematoxylin and Eosin staining  
Haematoxylin and Eosin staining (H&E) was used to assess the general morphology 
of the tissue section. The samples were stained for 3 to 5 minutes in Mayer’s 
Haematoxylin (Thermo Fisher Scientific, Leicestershire), washed for 2 minutes in 
running water, differentiated in 1% acid alcohol and stained for 3 minutes in Eosin 
(VWR International, Leicestershire, UK). The slides were then washed in running 
water and dehydrated in 100% industrial methylated spirit, air–dried, cleared and 
mounted with DPX mounting solution (Sigma Aldrich, UK).  
 
2.19  Morphometric assessments  
The histochemical staining of submandibular glands was used for measuring 25-40 
random acini (µm2) per sample and the mean area calculated using the Image J 
software version 1.46  (NH Maryland, MD, USA). 
 
2.20  Immunohistochemistry 
For immunohistochemistry, tissue sections were firstly de-waxed, dehydrated in 
xylene, followed by incubation in ethanol and rehydrated in distilled water. Next, the 
sections were treated with 3% hydrogen peroxide for 10 minutes to reduce the 
endogenous peroxidase. Sections were further treated with preheated citric acid 
buffer solution (pH 6.0), as an antigen retriever. Sections were cooled in cold water 
and incubated with 2% BSA blocking solution to avoid unspecific binding. Later, 
sections were incubated with the primary antibody at room temperature to localize 
the protein of interest. Next, the sections were washed with 1% TBST prior to 
incubation with the secondary biotinylated antibody for 30 minutes (Dako, UK). Then, 
they were incubated for another 30 minutes with streptavidin-biotin complex 
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horseradish peroxidase (StreptABC-HRP; Vector Laboratories, UK). The 
visualization of the peroxidase activity was carried out by diaminobenzidine 
tetrahydrochloride (DAB; Sigma Aldrich, UK). The DAB was applied to the sections 
for 10 minutes, followed by nuclear counterstaining for 30 seconds with Mayer’s 
haematoxylin. 
 
2.21  Statistical analysis  
All statistical analysis was carried out by ANOVA test followed by Tukey’s test or 
two-tailed unpaired t-test using Microsoft Excel 2011 (Microsoft, Redmond, WA) and 
Prism statistical program version 19 (Hampshire, UK). Data were calculated as mean 
with the standard error of the mean (Mean ±S.E.M) and p-values less than 0.05 were 












3 THE INFLUENCE OF mTOR AND WNT ON SALISPHERE 
DEVELOPMENT 
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3.1 Introduction  
Within the mTOR pathway, mTOR is upregulated by an abundance of growth factors 
such as IGF, cellular energy via AMP-activated protein kinase (AMPK) or amino 
acids via Rag mediators (Shaw, 2008). Wnt is also associated with mTOR activity 
and is an important signalling protein that regulates cell proliferation, stem cell 
maintenance and stem cell self-renewal (Nusse et al., 2008, Choo et al., 2006). The 
Wnt signalling mechanism of action involves the cellular release of Wnt proteins, 
which binds to the Frizzled (Fz) and low-density lipoprotein (LDL) receptor complex. 
Upon Wnt binding to the receptor, signals are transduced to different intracellular 
proteins, which include Dishevelled (Dsh), glycogen synthase kinase-3β (GSK-3β), 
Axin, Adenomatous Polyposis Coli (APC) and β-catenin. The transcriptional 
regulator β-catenin is usually degraded in the absence of Wnt signals. However, in 
the presence of Wnt, β-catenin is accumulated in the cytoplasm and subsequently in 
the nucleus where it binds to DNA to initiate transcription (Figure 3.1) (Logan and 




Figure 3.1 Wnt signalling in the absence and the presence of Wnt proteins. Left panel 
shows the degradation of β-catenin due to the absence of Wnt signals. Right panel shows 
the accumulation of β-catenin in the cytoplasm and in the nucleus due to the binding of Wnt 
protein to the Frizzled/LRP receptor, resulting in the transcriptional activation [Modified from 
(Logan and Nusse, 2004)]. 
 
The interaction between mTOR and Wnt might occur specifically via GSK3-β/TSC2, 
which negatively regulates mTOR activity (Rosner et al., 2008). Wnt phosphorylates 
GSK3-β, which in turns inhibits TSC2 and activates mTOR. Inoki et al. (2006) 





Figure 3.2 The relationship between mTOR and Wnt signaling. mTOR can be regulated 
by Wnt via GSK3-β, where the inhibition of GSK3-β results in the activation of mTOR via 
TSC2 [Modified from (Wu and Pan, 2010)]. 
 
Although, there are different classes of Wnt agonists such as Norrin and R-spondin, 
the GSK3-β inhibitor such as LiCl, have been also used for Wnt stimulation (Klein 
and Melton, 1996; Hedgepeth et al., 1997; MacDonald et al., 2009). Since GSK3-β 
degrades β-catenin. Interestingly, GSK3-β is a mutual component of mTOR and Wnt 
signalling, LiCl could stimulate both mTOR and Wnt by inhibiting GSK3-β (Figure 
3.2) (Sarkar et al., 2009; Wu and Pan, 2010).  
 
Upon activation, mTOR regulates several roles at cellular level such as protein 
synthesis, cell growth and cell proliferation. Protein synthesis involves three main 
stages: initiation, elongation and termination (Wang and Proud, 2006). The first 
stage of protein synthesis is regulated by 4e-bp1, whereas the other two stages are 
regulated by S6 kinase (S6K) (Magnuson et al., 2012).  
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These processes are highly regulated and occur when the main two substrates are 
phosphorylated. Specifically, two genes encode for SK6, S6K1 and S6K2, and both 
are responsible for cell size and growth, whereas the 4e-bp1 regulates the cap-
dependent translational machinery (Pende et al., 2000; Sonenberg and Hinnebusch, 
2009; Fenton and Gout, 2011). The main substrate of S6K is S6 ribosomal protein 
(S6rp) (Ferrari et al., 1991). However, 4e-bp1 is classified as an inhibitor of 
translation initiation by binding to 4IF4E, which is a component of the 4eIF4 complex, 
hence regulating the cap-dependent translation process.  
 
 
Figure 3.3 A general scheme of the translation initiation stage of protein synthesis. 
Inactive 4e-bp1 is usually coupled with eIF4e; however, when mTOR is activated 4e-bp1 is 
phosphorylated and dissociates from the eIF4e resulting in the formation of the eIF4F 
complex. The eIF4e and eIF4G are phosphorylated as a consequent of 4e-bp1 release, as 
well as a consequence of MNK1/2 phosphorylation (Hou et al., 2012). 
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The eIF4e complex consists of three polypeptides which are: eIF4E, eIF4A and 
eIF4G. eIF4E is a cap binding protein, eIF4A is a RNA helicase and eIF4G is a 
scaffolding protein (Sonenberg and Hinnebusch, 2009). The phosphorylation of 4e-
bp1 initiates translation through the dissociation of eIF4E from 4e-bp1 and 
interacting with eIF4G (Heesom and Denton, 1999; Scheper and Proud, 2002). 
Hence, rapamycin is able to block the translation initiation through the de-
phosphorylation of 4e-bp1 and the formation of the eIF4G complex (Figure 3.3) 
(Scheper and Proud, 2002). In addition, mitogen activated protein kinase MAPK 
interacting protein kinase MNK1/2 can phosphorylate eIF4E (Pyronnet, 2000). MNK1 
and MNK2 were discovered by Fukunaga and Hunter (1997) and Waskiewicz and 
Cooper (1997). The two MNKs share a high sequence homology in their catalytic 
and terminal domains but MNK1 can bind both to ERK and p38 MAPK, whereas 
MNK2 binds to ERK only (Waskiewicz et al., 1997; Slentz-Kesler et al., 2000; 
Scheper and Proud, 2002). 
 
After the initiation stage, S6K1 is recruited and phosphorylates different substrates 
including PDCD4, eIF4B and S6 rp. It is also important to note that S6 rp 
phosphorylation plays a role in cell growth (Magnuson et al., 2012). In addition, both 
4e-bp1 and S6K are believed to be involved in cell proliferation and cell cycle 
progression. The overexpression of eIF4E is also associated with the increase in the 
cell size (Fingar et al., 2004). Hence, both mTOR substrates cooperate in cellular 
processes, albeit the role of each substrate for each process (e.g. protein synthesis) 
is variable.  
 66 
mTOR is considered a key regulator of protein translation, therefore it is important for 
regulating cell growth and maintaining organ homoeostasis  (Murakami et al., 2004; 
Lloyd, 2013). The dysregulation of mTOR is involved in aging and various diseases 
such as cardiac hypertrophy (Soesanto et al., 2009; Johnson et al., 2013), and 
tumour growth in cancer such as ovarian cancer and hepatocellular carcinoma (Zhou 
et al., 2010; No et al., 2011; Populo et al., 2012).  
 
Since the mTOR network is involved protein synthesis, cell proliferation and cell 
growth and most importantly it is inactivated in normal salivary glands, the first 
objective was to understand the role of mTOR during salisphere development. In 
addition, the novel activation of mTOR in atrophic glands implies that it could be 
involved in regeneration. For these reasons, mTOR was selected as the focus of this 
project. Several inhibitors have been used such as rapamycin, LiCl, DKK1 inhibitor 
(which targets Dickkof-1) and MNK1/2 inhibitor to explore the effects of suppressing 
upstream and downstream regulators of mTOR on salispheres formation and 
development. 
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3.2 Materials and methods 
3.2.1 Experimental design  
Cultured salispheres were treated with different inhibitors at day 0 of culture. At day 4 of 
culture, salispheres were counted, morphologically assessed and collected for further 
analysis. 
 
3.2.2 Salivary glands stem/progenitor cell culture 
Salispheres were isolated and cultured as described in section 2.2. Plated cells in 12-
well dishes were directly treated with the inhibitors in triplicates.  
 
3.2.3 Treatments 
Cells were treated from day 0 with rapamycin (Rapa), LiCl (Sigma, UK), a co-treatment 
of rapamycin and LiCl (Rapa+LiCl), mouse recombinant Dickkof-1 (DKK1) inhibitors 
(R&D systems, Bio-Techne Ltd, UK) and MNK1/2 inhibitors (Merck Millipore, Merck 
Chemicals Ltd., UK). The table below illustrates the concentrations which have been 










Rapamycin 22 nM 
LiCl 10 mM 
DKK1 20 ng/ml 
60 ng/ml 
100 ng/ml 




Table 3.1 Concentrations of rapamycin, LiCl, DKK1 inhibitor and MNK1/2 inhibitor 
used during salispheres formation (day 0 – day 4). 
 
3.2.4 Cells/salispheres counting  
Around 2 x 106 cell/ml of cells were plated into each well. At day 4 of culture, 
salispheres were counted as explained in section 2.3. 
 
3.2.5 Imaging  
Cells and salispheres were imaged at day 1, 2, 3 and day 4 of culture at a 
magnification of 20x as well as imaging salispheres at day 4 of culture at 10x and 
40x as described in section 2.4.  
 
3.2.6 Size of salispheres  
Size of cells and salispheres was measured at day 1, 2, 3 and day 4 of culture. In 
addition, size of salispheres was also measured at day 4 post treatment as 
described in section 2.5.   
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3.2.7 Salispheres collection  
Cells and salispheres were collected at day 0, 1, 2, 3 and day 4 of culture as 
explained in section 2.6.  
 
3.2.8 Immunoblotting 
Gel electrophoresis and immunoblotting were carried out to measure mTOR activity 
as described in section 2.7. 
 
3.2.9 Antibodies  
All immunoblots were probed overnight at 4°C in TBST containing 5% BSA including 
p-4e-bp1 and p-S6 rp and anti β-actin, blots were probed for 2 hours only in TBST as 
described in section 2.7. The table below shows the antibodies and dilutions which 
have been used in this chapter:  



































     
Table 3.2 Antibodies which have been used for immunoblotting. 
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3.2.10 Densitometry 
Quantification of band intensity was determined as mentioned in section 2.9. 
 
3.2.11 MTS Assay  
Cell proliferation levels were measured as described at day 0, 1, 2, 3 and day 4 of 
culture as described in section 2.10.  
 
3.2.12 Organoid formation assay  
Salispheres were cultured at day 4 in collagen/matrigel matrix according to the 
protocol explained in section 2.11.  
 
3.2.13 Statistical analysis  
Statistical analysis was performed using one-way ANOVA and Tukey’s test. 
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3.3 Results  
3.3.1  Parallel relationship of mTOR to salispheres formation 
The process of salispheres formation relies on the aggregation of single cells in 
order to form a sphere around 2 to day 3 of culture (Figure 3.4, A). The area size of 
salispheres showed a gradual increase over time in culture (p<0.05) (Figure 3.4, B). 
Similarly, the MTS values gradually increased, but the highest value appeared at day 
3 (p<0.02) and day 4 (p<0.005) of culture compared to day 1 of culture (Figure 3.4, 
C). 
 
mTOR was activated during the formation of salispheres, where the phosphorylation 
of mTOR substrates, 4e-bp1 and S6 rp, were clearly visible from the first day to the 
fourth day of culture, but unphosphorylated 4e-bp1 at day 0. The phosphorylation of 





Figure 3.4 Stages of salispheres formation. A) Images showing the stages of salispheres 
formation (scale bar = 50 µm) B). Area size of salispheres showed a gradual increase in 
corresponding to the clumping of single cells to form a salisphere (*p=0.05). C) A steady 
increase in MTS values during the growth of salispheres in culture as the highest values 
appeared at day 3 (*p=0.0187) and day 4 (*p=0.0027) compared to day 1 of culture. Data 





Figure 3.5 Growing salispheres in vitro exhibit mTOR activity. A) Immunoblot of p-S6 rp 
and p- 4e-bp1 showed that mTOR was active at all stages of salispheres development, 
except day 0 where 4e-bp1 was not expressed. B) Relative expression of S6 rp normalized 
to β-actin showed a gradual phosphorylation of S6 rp expect low level of expression at day 0 
compared to day 1, 2, 3 and day 4 (***p<0.0001). C) Relative expression of 4e-bp1 
normalized to β-actin showed hyper-phosphorylation of 4e-bp1 at all stages of salispheres 
formation except day 0 where 4e-bp1 was hypo-phosphorylated (***p<0.0001). Data 
represented as mean±S.E.M, n=4. 
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3.3.2 Inhibition by rapamycin demonstrates the importance of 
mTOR for growing salispheres in vitro 
To understand the importance of mTOR for salispheres formation, mTOR was 
inhibited by rapamycin. The incubation of salispheres with rapamycin from day 0 
revealed the capability of rapamycin to inhibit mTOR activity in developing 
salispheres as indicated by a significant reduction in size (p<0.005) and number 
(p=0.0293) (Figures 3.6 A, B and C). Although rapamycin significantly affected 
mTOR expression by complete inhibition of S6 rp (p=0.0010), it did not fully inhibit 





Figure 3.6 Effects of rapamycin, LiCl and the co-treatment of rapamycin and LiCl on the 
primary culture of salispheres. A) Images of untreated salispheres (control) and treated 
salispheres with rapamycin, LiCl and co-treated salispheres with rapamycin and LiCl at day 4 
of culture. The small and large scales represent 20 µm and 50 µm respectively B) Size of 
salispheres were affected by the different treatments, specifically, rapamycin resulted in a 
significant reduction (*p=0.02) whereas LiCl resulted in a significant increase in size compared 
to the control (***p=0.0004). A slight recovery in size was observed in treated salispheres with 
rapamycin and LiCl (p=0.2139). C) Number of salispheres after four days of treatment was 
significantly affected by rapamycin. Data represented as the mean±S.E.M, n=3. 
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3.3.3 Modulation of mTOR activity by other mechanisms 
The use of LiCl showed a significant effect on the size of salispheres (***p<0.0005) 
and an increase in number of salispheres, yet statistically the increase was 
insignificant (Figures 3.6, B and C). In terms of mTOR, LiCl might have some 
influence in stimulating mTOR via GSK3-β (Figure 3.8), specifically on the 
phosphorylation of 4e-bp1 (Figure 3.7, C), although no statistical significance was 
observed.  
 
The co-treatment of rapamycin and LiCl illustrated that salispheres were not capable 
of overcoming the action of rapamycin. However, the presence of LiCl with 
rapamycin affected the recovery of size but not number of salispheres. It also 
showed that LiCl was not able to recover mTOR activity in the presence of 




















Figure 3.7 The impact of rapamycin, LiCl and the co-treatment of rapamycin and LiCl 
on mTOR activity. A) Immunoblots of salispheres lysates, which were probed with p-S6 rp, 
p-4e-bp1 and β-actin. B) Rapaymcin treatment alone or combined with LiCl caused total 
inhibition in p-S6 rp expression (p<0.0001). C) However, the relative expression of p-4e-
bp1 was not fully abolished by rapamycin alone or in combine with LiCl. Data represented 





Figure 3.8 Effect of LiCl on the GSK-3 phosphorylation. A slight increase in p-GSK-3 
expression in treated salispheres with LiCl, however, the increase was insignificant 
(p=0.2861). Data represented as mean±S.E.M, n=3.   
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3.3.4 Rapamycin and LiCl affected organoid formation 
Untreated and treated salispheres with rapamycin and LiCl were cultured in a 
collagen/matrigel matrix to assess the effect of the treatments on the formation of 
acinar/ductal structures. Untreated salispheres were able to branch at days 5-7 of 
culture, while rapamycin treated salispheres did not survive. However, LiCl resulted 
in few formed ductal/acinar like structures compared to controls, and the majority 
preserved a spherical structure and increased in size overtime. Similarly, when 
rapamycin was combined with LiCl, salispheres preserved their spherical structure 





Figure 3.9 Ability of treated salispheres with rapamycin, LiCl and co-treatment of 
rapamycin and LiCl of forming organoids in collagen/matrigel matrix. Cultured 
untreated salispheres in a mixture of matrigel and collagen assisted the salispheres to 
develop ductal/acinar like structure. Budding of a normal sphere occurred within few days of 
culture, which is a similar feature to the branching morphogenesis of salivary glands. mTOR 
inhibition by rapamycin affected the survival of remaining salispheres. However, the 
administration of LiCl maintained the spherical structure of the salispheres and allowed the 
increase in size overtime. In addition, the use of LiCl with rapamycin occasionally allowed 




3.3.5 Wnt is not the main factor for mTOR activation 
Since LiCl is not a specific stimulator for mTOR as it acts on GSK-3β and it is a 
common component of Wnt and mTOR, a DKK1 inhibitor was introduced, which is a 
more specific inhibitor for Wnt signalling. Three concentrations were used to assess 
the optimal dose for inhibiting Wnt activity ranging from 20 to 100 ng/ml. The three 
doses of DKK1 inhibitor neither affected the formation nor the development of 
salispheres (Figure 3.10, A). Statistically, there was no difference in the number of 
salispheres between the control and the concentrations which were used 
(p=0.1896). However, the highest concentration of DKK1 inhibitor only showed an 
effect on the size of salispheres (p= 0.0066) (figures 3.10, B and C). In terms of the 
effect of DKK1 inhibitor on mTOR expression, the treatment neither reduced S6 rp 
expression (p=0.2028) nor 4e-bp1 expression (p=0.9958), where the expression of 




Figure 3.10 Effects of different concentrations of DKK1 inhibitor on size and number 
of salispheres. A) Treated salispheres with different concentrations of DKK1 inhibitor did not 
prevent the formation of salispheres. The scale bar represents 20 µm. B) Size of salispheres 
was significantly affected only when salispheres were treated with the highest concentration 
of DKK1 inhibitor compared to the control (*p=0.0066). C) Number of salispheres showed 
some variation but the differences were statistically insignificant (p=1.896). Data represented 






Figure 3.11 mTOR status in treated salispheres with 20, 60 and 100 ng/ml of DKK1 
inhibitor. A) Immunoblots of treated salispheres with three doses of DKK1 inhibitor, which 
were probed with mTOR substrates antibodies. B) mTOR was not affected by DKK1 inhibitor 
as the phosphorylation of S6 rp was comparable to the control (p=0.9722). C) In addition, the 
different ranges of DKK1 inhibitor did not show any significant effects on expression of 4e-
bp1 (p=0.8362). Data represented as the mean±S.E.M, n=6.  
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3.3.6 MNK1/2 inhibitor showed an effect on salispheres formation 
The three ranges of MNK1/2 concentrations used showed variable effects on salisphere 
culture. The formation of salispheres was affected by the MNK1/2 inhibitor, where the 
size of salispheres was gradually reduced with increasing the concentration of MNK1/2 
inhibitor (p=0.0037) (Figure 3.12). However, number of salispheres was variable among 
the different concentrations of MNK1/2 inhibitor and the inhibitor did not show any 
significant differences (p=0.0865). Interestingly, the MNK1/2 inhibitor showed a 
significant reduction in the phosphorylation of 4e-bp1 only but not s6 rp, but insignificant 





Figure 3.12 Effects of MNK1/2 on salispheres culture. A) Images of salispheres with/out 2.2 
µM and 3 µM of MNK1/2 inhibitor. The scale bar represents 20 µm. B) Average size area of 
salispheres was reduced with an increase in the concentration of MNK1/2 inhibitor. C) Number 
of salispheres was not significantly affected by the treatment. Data represented as 






Figure 3.13 mTOR status in salispheres post treatment with 2.2 µM and 3 µM of MNK1/2 
inhibitor. A) Immunoblot showing the effects of MNK inhibitor on the phosphorylation of eif4e 
and 4e-bp1. B) Relative expression of eif4e was slightly suppressed by the action of MNK 
inhibitor. C) A gradual decrease in the phosphorylation of 4ebp1 paralleled increasing the 
concentration of MNK1/2 inhibitor. However, only 4e-bp1 expression was significantly affected by 




Although mTOR activity drives cap-dependent protein translation, it is inactivated in 
normal mature salivary glands. Activity can be induced by the ductal ligation of the 
submandibular gland (Silver et al., 2010; Bozorgi et al., 2014) and therefore thought 
to be important for regeneration, and potentially for stem/progenitor cells. As 
previously shown, mTOR is associated during salivary gland atrophy; this study was 
designed initially to understand if mTOR is important for growing salispheres in vitro.  
 
Unlike normal salivary glands, cultured salispheres in vitro exhibit mTOR activity, 
with a gradual increase during the formation and development of salispheres. 
Presumably, tissue digestion and culture is sufficient to activate mTOR by day 1, as 
they require insulin for their culture and insulin is one of the upstream regulators of 
mTOR in several different cell types  (Scott et al., 1998; Wang et al., 2006).  
 
The parallel increase in size, number and mTOR activity during the formation of 
salispheres implies that mTOR is a factor involved in the formation of salispheres, as 
it is considered master of cell growth (Laplante and Sabatini, 2009). This observation 
is supported by mTOR inhibition by rapamycin, which illustrated how crucial mTOR 
is for salisphere growth (Fingar et al., 2002; Inoki et al., 2006). Similar to work on 
salispheres, Paliouras et al. (2012) has shown that neurosphere formation 
decreased with increased concentrations of rapamycin, and mTOR also plays a role 
in maintaining neural progenitor pools (Sato et al., 2010; Paliouras et al., 2012).  
There are several upstream regulators of mTOR activity such as growth factors and 
Wnt signalling. For this reason, LiCl was introduced in this study as it functions 
through the GSK-3, resulting in the activation of mTOR.  
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The action of LiCl on enhancing mTOR via GSK-3 and TSC2 interaction has shown 
several impacts on salispheres growth. Interestingly, LiCl resulted in a significant 
increase in the size of the salispheres and slight increase in their numbers (Figure 
3.6). It also showed that it has some influence on mTOR activity, specifically the 
expression of 4e-bp1, but not the expression of S6 rp (figure 3.7). The observation 
that LiCl can activate both Wnt signalling and mTOR via GSK-3, brought into 
question which signalling pathway (mTOR or Wnt) was responsible for the increase 
of size and numbers of salispheres (Silva et al., 2010; Phiel and Klein, 2001). 
Although the phosphorylation of GSK-3 was slightly increased in the LiCl treated 
salispheres (Figure 3.8), this may indicate that LiCl influenced mTOR activity.  
 
The dual treatment of rapamycin and LiCl suggested that LiCl may act solely via the 
mTOR pathway rather than activating a separate pathway such as Wnt (Montagne et 
al., 1999). LiCl treatment suggests that Wnt signals were not able to recover mTOR 
activity in the presence of rapamycin. This may highlight GSK-3 as a regulator of 
mTOR activity as it has been demonstrated that deleting GSK-3 affected 
neurosphere proliferation (Ka et al., 2014). In addition, the co-treatment of rapamycin 
and LiCl illustrated that mTOR is an essential factor of salisphere growth; hence, the 
combination would not assist the maintenance of salispheres by inhibiting mTOR 
and stimulating Wnt as observed in hematopoietic stem cells (Huang et al., 2012). 
This implies that mTOR activity is crucial for the survival of salispheres.  
 
As LiCl could stimulate both mTOR and Wnt signalling, the DKK1 inhibitor was 
introduced, which acts by binding to LRP6 in order to prevent Wnt and frizzled 
interaction (Niehrs, 2006). The effect of the DKK1 inhibitor would explain if Wnt is an 
essential upstream regulator of mTOR. The effects of the DKK1 inhibitor and 
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rapamycin treatments on salispheres suggest that mTOR is a fundamental pathway 
for their development (Maimets et al., 2016). The DKK1 inhibitor significantly affected 
the size of salispheres but not mTOR signalling, suggesting that other upstream 
regulators might be responsible for keeping mTOR active in the absence of Wnt 
signals which is the usual stimulator of stem cells (Figure 3.11) (Nusse, 2008). 
Although the highest dose of the DKK1 inhibitor showed some effects on the culture 
of salispheres, the effects caused by rapamycin was still more potent than the effects 
caused by the DKK1 inhibitor. This might suggest that the potency of the inhibitor 
varies among each other as IWR-1 for example has shown considerable effect on 
salispheres culture compared to IWP-2 (Maimets et al., 2016).  
 
In contrast to the upstream regulators, evaluating the effect of inhibiting the 
downstream effectors of mTOR by MNK1/2 inhibition, which is involved in the 
assembly of the 4efie complex, helped in understanding different aspects of mTOR 
inhibition (Proud, 2015). The low level of p-eif4e expression in treated salispheres 
suggests that the translational process is reduced but still active, which may improve 
their survival (Figure 3.12). However, this reduction was not potent as the effects 
caused by rapamycin. As previous study found that both MNK1/2 are responsible for 
the phosphorylation of ei4fe, but not responsible for cell growth and development 
(Ueda et al., 2004). This also suggests that 4e-bp1 expression might be the factor for 
keeping the translational machinery switched on in the absence of MNK1/2 action. In 
addition, it has been shown that the de-phosphorylation of eif4e is dependent on 4e-
bp1 levels and MNK1/2 is not essential for the cap-translational process (Knauf et 
al., 2001; Muller et al., 2013).  
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In conclusion, examining different aspects of mTOR illustrated the necessity of 
mTOR signaling for healthy growing salispheres. The use of rapamycin emphasized 
the importance of mTOR for developing salispheres and the potency of rapamycin as 
a mTOR inhibitor. Furthermore, the effects of LiCl on salisphere culture suggest that 












4 SALISPHERE DEVELOPMENT FROM NORMAL, 
LIGATED and DE-LIGATED GLANDS 
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4.1 Introduction  
In humans, there are several conditions that can contribute to the atrophy of salivary 
gland such as sialadenitis, Sjögren’s syndrome and radiotherapy. Ligation of the 
main excretory duct in rodents is commonly used to understand salivary atrophy as 
the histological appearance is similar to human disease (Cummins et al., 1994; 
Silver et al., 2010).  
 
Figure 4.1 Histology of submandibular gland after seven days of ligation (with 
courtesy of Naomasa Kawashima). 
 
Introducing injury through ligation of the main excretory duct causes the salivary 
glands to atrophy. The atrophy of the gland includes apoptosis, deletion of acinar 
cells, necrosis, autophagy and extensive proliferation of the myoepithelial cells, as 
well as mitotic proliferation of ductal cells (Burford-Mason et al., 1993; Burgess et al., 
1996). The removal of acinar cells by apoptosis in chronic sialadenitis and Sjögren’s 
syndrome is comparable to experimental ligation-induced atrophy, which makes this 
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experimental procedure a useful model for understanding salivary glands atrophy 
(Kong et al., 1997; Harrison and Badir, 1998; Takahashi et al., 2000).  
 
Removal of the ductal obstruction leads to the regeneration of salivary glands 
showing an improvement in the glandular weight, branching structures and the area 
size of the acini (Cotroneo et al., 2008). The ligation/de-ligation procedure also 
induces the expression of the neonatal proteins such as SMG-B1 and B2, which are 
normally expressed in the acinar cells of developing salivary glands and the 
intercalated duct of adult salivary glands. Another protein named parotid secretory 
protein (PSP) is only expressed during the development of salivary glands, but no 
expression observed in adult mature salivary glands. An injury model results in the 
expression of the embryonic prenatal pathways in the acinar cells, emphasizing the 
regenerative capacity of salivary glands post-injury (Cotroneo et al., 2010).  
 
The de-ligation of the salivary gland duct helps in understanding the mechanism by 
which salivary glands can regenerate post-injury. Earlier studies believed that 
regeneration could occur from resident acinar cells, whereby they proliferate directly 
after the removal of injury and from remaining ductal cells (Bhaskar et al., 1966; 
Tamarin, 1971a; Tamarin, 1971b; Takahashi et al., 2004). In the context of salivary 
gland regeneration, label-retaining studies have provided evidence of the presence 
of stem/progenitor cells in the parenchymal compartments, similar to the histological 
studies in regenerating salivary glands. The presence of a stem/progenitor cell pool 
is important for tissue maintenance, lineage commitments and differentiation to 
different salivary gland cell types (Lombaert et al., 2011; Chibly et al., 2014). Several 
studies have shown the location of these progenitor cells in the ductal compartment 
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and their ability to producing both acinar and ductal cells (Denny and Denny, 1999; 
Man et al., 2001; Nanduri et al., 2011).  
 
As previously stated, mTOR is inactive in adult rodent normal salivary glands, but 
4e-bp1 is hypo-phosphorylated and is localized mainly in acinar cells.  However, 
mTOR becomes activated during ductal ligation and the expression of 4e-bp1 is 
localized around the lobular structure, suggesting that mTOR is playing a role in 
protecting remaining acinar cells (Silver et al., 2010). In addition, the inhibition of 
mTOR may also delay atrophy following ductal ligation of the submandibular gland, 
specifically atrophic acinar cells (Bozorgi et al., 2014).  
 
In this chapter, mTORC2 will be briefly explained as ductal ligation, which has been 
carried out in this chapter, affected salisphere culture. Also the second complex of 
mTOR may play a role in migration and cytoskeletal rearrangement. Although less is 
known about the function of mTORC2 compared to mTORC1, (mainly due to the 
lack of a specific inhibitor for mTORC2 activity), mTORC2 is thought to regulate 









Figure 4.2 Upstream and downstream effectors of mTORC2. The activation of mTORC2 
by growth factors and ribosomes is thought to affect AKT, GSK1 and PKCα. mTORC2 
activation is important for cell survival and cytoskeletal rearrangement (Laplante and 
Sabatini, 2009; Zinzalla et al., 2011). 
 
Growth factors are not only responsible for activating mTORC1, but also mTORC2 
via the PI3K. However, the activation beyond the PI3K is distinctive between the two 
complexes (Zinzalla et al., 2011; Sparks and Guertin, 2010).  
 
Unlike mTORC1, mTORC2 is considered insensitive to rapamycin, but prolonged 
treatment with rapamycin in certain cell types can inhibit mTORC2 (Sarbassov et al., 
2006; Sparks and Guertin, 2010). The second generation of mTOR inhibitors such 
as torin1 has been designed to target both complexes mTORC1 and mTORC2 
(Guertin and Sabatini, 2009).  
 
Several studies have shown the involvement of mTORC2 in cytoskeletal 
rearrangement. For example, mTORC2 has shown a role in neuron morphology, 
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suggesting that mTORC2 aberration can be related to brain diseases (Angliker and 
Ruegg, 2013). In addition, the role of mTORC2 in the cytoskeletal remodeling can 
also affect the lineage selection of mesenchymal stem cells (Sen et al., 2014). 
However, the second complex of mTOR is not the only factor that acts on 
cytoskeletal rearrangement, there are other signalling pathways, which are 
associated with the cytoskeletal remodeling such as RhoA/ROCK signalling.  
 
Rho kinase is a serine/threonine kinase discovered to be an effector of the small 
GTPase Rho (Leung et al., 1995, Amano et al., 2010). Rho kinase is comprised of 
two members ROCK1 and ROCK2. Both ROCK1 and ROCK2 share 62% of their 
overall amino acid identity and have similar substrate specificity.  They are 
expressed in most tissues. However, ROCK2 appears to be highly expressed in 
brain and muscles, whereas ROCK1 is highly expressed in non-neural tissues 
(Leung et al., 1996; Nakagawa et al., 1996). It is responsible of the organization of 
the cytoskeleton, formation of stress fibers and focal adhesions, as well as cell 
polarity (Amano et al., 2010). The activation of ROCK by the RhoA consequently 
phosphorylates myosin light chain (MLC) and LIMK, which in turns inactivate cofilin 




Figure 4.3 RhoA/ROCK signaling. ROCK activation relies on RhoA activity. The activation 
of ROCK by RhoA leads to the phosphorylation of MLC and the phosphorylation of LIMK, 
which inhibits cofilin. This cascade results in actin cytoskeletal rearrangement (Riento and 
Ridley, 2003b). 
 
ROCK can be inhibited by the antagonist, Y-27632 (referred as ROCKi in this study) 
(Ishizaki et al., 2000). ROCK inhibition has shown a role in axonal regeneration in 
injured central nervous system (Fournier et al., 2003). In addition, it has also shown 
a role in the survival of cryopreserved human embryonic stem cells (Li et al., 2009, 
Martin-Ibanez et al., 2009). 
 
The objective of this chapter was to determine the effect of injury on salisphere 
culture and to investigate if mTOR activity is affected in grown salispheres from 
injured glands. 
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4.2 Materials and methods 
 
4.2.1 Experimental design 
Salispheres were isolated and cultured from ligated and de-ligated glands for 4 and 8 
days. Similarly, normal salispheres were cultured with ROCKi (10 µM) for 4 days and 
8 days. All salispheres were morphologically assessed at day 4 of culture and 
collected at day 8 of culture to evaluate the morphological similarities and the 
expression levels of cytoskeletal proteins. 
 
Figure 4.4 A schematic demonstrating the experiments performed in this chapter. 
Salispheres were cultured from ligated/de-ligated glands and collected at two-time points; 
day 4 and day 8. Next, only salispheres from ligated glands were used to compare the 
morphological similarities and differences to torin1 and ROCKi treated salispheres, to also 
assess mTOR activity and expression levels of cytoskeletal proteins. 
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4.2.2 Ligation/de-ligation of submandibular glands 
Ligation was performed firstly by anesthetizing the mice with xylazine (5 mg/Kg) 
/ketamine (25 mg/Kg) i.p injections. After reaching sufficient depth of anaesthesia, a 
0.5 cm skin incision was made in the centre of the neck. A blunt dissection was 
performed, where the fat surrounding salivary glands was dispersed and the left 
submandibular excretory duct was ligated by a 6-0 Ethivon suture (Johnson and 
Johnson Intl, Brussels, Belgium) or a metal clip. Following the surgery, the neck was 
sutured and the mice were allowed to recover from anesthesia. The mice were 
administered analgesics (buprenorphine, 10µg/kg) and were maintained in a warm 
room. Seven days post ligation; the mice were terminally anaesthetized with an 
overdose of pentobarbitone. For de-ligation experiments, mice were anesthetized as 
previously after seven days of ligation with a xylazine/ketamine i.p injection and the 
clip was removed. The neck was sutured and the mice were allowed to recover as 
previously explained. The mice were terminally anaesthetized after seven days of 
de-ligation and given an overdose of pentobarbitone. At the end of the experiment, 
the submandibular glands were collected and weighed before processing for 
salisphere culture.  
 
4.2.3 Salivary gland stem/progenitor cell isolation and culture 
Salispheres were isolated and cultured according to the protocol described in section 
2.2. Gland weights were taken into consideration for determining volumes required of 
collagenase, hyaluronidase and CaCl2 in the digestion step. In addition, cells were 
plated according to the gland weights to maintain similar seeding densities, as 
ligation and de-ligation were performed in one gland/animal.  
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4.2.4 Torin1 and ROCKi treatments 
Cultured salispheres from un-operated glands were treated at day 0 with 10 nM of 
Torin1 (R&D systems, UK) and 10 µM of ROCK inhibitor (Millipore, Hertfordshire, 
UK). The selection of treatment concentrations was determined by preliminary 
experiments. 
 
4.2.5 Salispheres counting 
Salispheres from ligated, de-ligated glands and the contralateral glands were 
processed for counting at day 4 of culture by determining the average of 3 fields at 
10x magnification.  
 
4.2.6 Size of salispheres 
The size of salispheres from ligated and de-ligated glands was measured using 
Image J software at day 4 of culture, as described previously in section 2.5. 
 
4.2.7 Salispheres imaging and collection 
Salispheres were imaged prior to collection at day 4 and day 8 of culture. ROCKi 
treated salispheres were imaged at day 4, 6 and 8 of culture as previously described 
in section 2.4 and collected as described in section 2.6.  
Adherent cells were collected at day 8 of culture from ligated and ROCKi treated 
samples, including the un-operated floating salispheres. Adherent cells were 
collected after washing with PBS and scraping with RIPA lysis buffer.  
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4.2.8 Immunoblotting 
Gel electrophoresis and immunoblotting were carried out as previously described in 
section 2.7.  
 
4.2.9 Antibodies 
























     
Table 4.1 Antibodies used in this chapter. 
 
All immunoblots were probed overnight including p-4e-bp1 and p-S6 rp as previously 
described in section 2.8. 
 
4.2.10 Statistical analysis  
Statistical analysis was performed using one-way ANOVA and Turkey’s multi-
comparison test as previously described in section 2.21.  
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4.3 Results  
4.3.1 Glandular assessment 
Ligation of the main duct of the submandibular gland resulted in a significant 
reduction in the weight of submandibular glands (p=0.0002) (40.8±2.6g, n=5) 
compared to un-operated glands (62.9±1.2g, n=5), whereas the contralateral gland 
was significantly larger than the control (p=0.0006) (82.2±4.6g, n=5). The removal of 
the clip affected the glandular weights, where a slight recovery was observed 




Figure 4.5 Effect of ligation/de-ligation on gland weights. Ligation of the submandibular 
glands (lig) caused a significant reduction in gland weights (p=0.0002) and a significant 
increase in the gland weights of the contralateral glands (Cont.lig) (p=0.0006). In contrast, 
de-ligation resulted in recovery of the gland weights (de-lig) (p=0.0232), whereas the 
contralateral glands of de-ligated glands (Cont.lig) were still significantly higher than the 
control (p=0.0021). Data represented as mean±SEM, n=5.  
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4.3.2 Injury affected salispheres culture 
Injury initially affected the number and size of cultured salispheres. For example, 
ligation caused a reduction in number of salispheres; although, statistically the 
reduction was insignificant. While, the number salispheres from the contralateral 
gland of the ligated submandibular gland were significantly higher (p=0.0430) 
compared to the number of salispheres at day 4 of culture from un-operated glands 
(Figure 4.6, B). The removal of injury helped in the slight recovery of the number of 
salispheres, but the recovery is still very low compared to cultured salispheres from 






Figure 4.6 Number and size of salispheres post ligation and post de-ligation. A) Five 
images representing salispheres at day 4 of culture by the phase-contrast microscopy (Scale 
bar = 50µm). B) Number of salispheres was reduced post injury compared to the un-
operated glands (control), except the contralateral gland of ligated gland showed a significant 
increase in number of salispheres (*p=0.0430). C) Size of salispheres were significantly 
reduced post injury compared to the control (***<0.0001), except cultured salispheres from 
contralateral glands of ligated glands (p=0.2602) was similar to the size of the control. Data 
represented as mean±S.E.M, n=3.  
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4.3.3 Injury causes morphological changes to cultured salispheres 
One of the main characteristics of salisphere culture is growing in a non-adherent 
form. However, the salispheres post-injury behaved differently around day 6 of 
culture.  They firstly grew in suspension (Figure 4.6, A), before adhering to the 
plastic dish around day 6. Later, they lost their spherical structure and spread out 
over time forming fibroblastic-like structures (Figure 4.8).  	  
To assess possible reasons for these changes, two inhibitors have been used to 
treat salispheres from un-operated glands. Torin1 and ROCKi are inhibitors of 
mTORC2 and ROCK signalling respectively as both signaling pathways are involved 
in the cytoskeletal rearrangement. 
 
The use of torin1 to inhibit mTORC2 initially affected the survival of salispheres, and 
likely inhibited both mTOR complexes. Similarly, to rapamycin, torin1 resulted in a 
reduction in the number of floating salispheres (Figure 4.7).  In addition, no adhesion 
of remaining salispheres was observed in the presence of torin1. However, ROCKi 
affected normal salispheres similarly to salispheres derived from an injured gland. In 
addition, the cell viability increased over time, where the highest proliferation level 
was observed at day 8 of culture (p=0.0002) (Figure 4.9).  
 	  
The expression of focal adhesion kinase (FAK) and cytokeratin5/8 (CK5) helped in 
determining the similarities between cultured salispheres from an injured gland and 
treated normal salispheres with ROCKi as ROCK is involved in the cytoskeletal 
rearrangement. The expression of p-FAK and CK5 was significantly higher in both 
cultured salispheres from ligated glands and treated salispheres with ROCKi, while 
CK8 expression was unaffected by ligation or ROCK inhibition (Figure 4.10). 
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Figure 4.7 Morphological differences between cultured salispheres from un-operated 
glands, ligated glands, ROCKi and torin1 treated salispheres. Isolation and culture of 
salispheres from an injured gland resulted in the adherence of salispheres and loss of 
spherical structure, similar to the effect of inhibiting ROCK signaling by ROCKi. Torin1 
neither helped in the survival of the salispheres nor caused them acquire similar morphology 




Figure 4.8 Stages of salisphere adhesion by ROCKi. Treatment at day 0 with ROCKi 
caused to the salispheres to adhere at around day 6 of culture. They spread out over time 
and the spherical structure disappeared, and was replaced with a fibroblastic-like structure 
after they are attached to the plastic dish. The scale bar represents 20 µm. 
 
Figure 4.9 Viability with and without ROCKI at two time points. ROCKi resulted in a 
significant increase cell proliferation at day 4 and day 8 of culture. The treatment significantly 
increased the proliferation at day 4 (p=0.0192) and day 8 of culture (***p<0.0001), compared 
to untreated salispheres at day 4. Cell proliferation was also higher at day 8 compared to 





Figure 4.10 Expression patterns of p-FAK and CK5/8 in adherent salispheres in ROCKi 
treated salispheres and grown salispheres from ligated glands. A) Immunoblot of 
untreated salispheres (control), ROCKi treated salispheres and cultured salispheres from 
ligated glands. B) The relative expression of p-FAK was not significant in ROCKi treated 
salispheres (p=0.0678) but was statistically significant in cultured salispheres from ligated 
glands (p=0.0214). B) Both ROCKi (p=0.0146) and injury (p=0.0206) affected the expression 
of CK5. D) While CK8 appeared unaffected by the by ROCKi or ligation. Data represented as 
mean±S.E.M, n=3.  
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4.3.4 mTOR activity is important for protein synthesis   
mTOR activity appeared to be an essential factor during normal salisphere formation 
and development. In this study, neither ROCKi nor ligation significantly affected the 
phosphorylation of 4e-bp1 and the phosphorylation of S6 rp. Although, there were 
some variations in the phosphorylation of S6 rp and 4e-bp1 compared to controls, 
the differences were statistically insignificant (Figure 4.11). 
 
Figure 4.11 mTOR status in treated salispheres with ROCKi and in growing 
salispheres from ligated glands. A) Immunoblot of mTOR expression in treated 
salispheres with ROCKi and growing salispheres from ligated glands. B) The relative 
expression of p-S6 rp shows insignificant differences among the three samples. C) The 




Since ligation/de-ligation is considered a good model for studying regeneration, 
these experiments were designed to explore if salisphere formation would be 
affected by injury. Cultured salispheres from injured glands would help in 
understanding the correlation between salisphere behavior and regeneration as they 
are thought to represent the pool of stem/progenitor cells, which possess 
regenerative properties. 	  
Grown salispheres from ligated glands illustrated that injury affected the 
characteristics of salispheres. First, the number of salispheres and glandular weight 
were significantly affected as both glandular weight and number of salispheres have 
been reduced, suggesting a correlation between the population of salispheres and 
atrophy (Bozorgi et al., 2014).  
 
Observations from de-ligation experiments imply that salispheres are responsible for 
gland recovery as numbers of salispheres improved compared to those grown from 
ligated glands. In addition, the ability of these salispheres to repopulate seven days 
post de-ligation suggests that the stem/progenitor cell pool was activated.  
 
Conversely, the significant increase in the number of cultured salispheres from 
contralateral glands suggests a potential compensatory hyperplasia caused by 
ligation. This compensatory hyperplasia was decreased after removal of the injury of 
the contralateral gland as the number of salispheres was reduced compared to 
number of salispheres during ligation. This suggests that salispheres are correlated 
with both atrophy and hyperplasia.  
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Cultured salispheres from injured glands acquired distinctive characteristics 
compared to cultured salispheres from un-operated glands or contralateral glands. 
The adhesion of salispheres following glandular injury suggests intrinsic signalling 
alteration occurred which affected the growth of salispheres. To investigate the 
possible factors that are involved in the adhesion of salispheres, mTORC2 and 
RhoA/ROCK were studied because both are associated with cytoskeletal 
rearrangements (Amano et al., 2010). Although torin1 can inhibit both complexes of 
mTOR, the objective of using torin1 was to explore if mTORC2 inhibition would lead 
to the adhesion of remaining salispheres. However, torin1 primarily appeared to 
affect the survival of salispheres similar to rapamycin, suggesting that mTOR 
signalling is fundamental to salisphere development. The effect of torin1 also 
suggests that mTORC2 is not associated with morphological changes and other 
factors that may be responsible for these alterations.  
 
In contrast, inhibiting RhoA/ROCK caused cultured salispheres to develop similar 
characteristics to injured glands, suggesting that RhoA/ROCK is involved in salivary 
gland atrophy. This was surprising as inhibition of ROCK is widely used in stem cell 
culture to prevent contact-inhibition of growth and several studies have used ROCKi 
for cryopreservation of embryonic stem cells (Watanabe et al., 2007; Li et al., 2009). 
 
Moreover, Lee and colleagues (2015) demonstrated that in the presence of 10 µM of 
ROCKi salispheres did not adhere to the plastic dish as observed in this study but 
prevented their senescence. Similar to results of this study, previous work has 
shown that ROCK inhibition effects salisphere proliferation and survival (Yu et al., 
2012; Okumura et al., 2009). 
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The significant up-regulation of p-FAK and CK5 suggest that RhoA/ROCK may play 
a role in morphological alterations. Presumably, other RhoA/ROCK related markers 
such as MLC are also upregulated (Riento and Ridley, 2003a). Another possibility is 
that injury might contribute to the differentiation of progenitor cells due to cellular 
distress. 
 
Since mTOR was active in cultured salispheres, experiments explored whether there 
are any differences in mTOR expression between growing salispheres from injured 
and normal glands. The presence of mTOR in all samples and the insignificance 
differences in S6 rp and 4e-bp1 expression imply that mTOR was not correlated to 
the adhesion of salispheres, but was mainly involved in cell growth. This is 
unsurprising because mTOR is responsible for protein synthesis (Wang and Proud, 
2006). These data also suggest that the variability of mTOR expression might have 
occurred depending on the level of protein synthesis and cell growth, and that the 
molecular mechanism of mTOR is different in glands compared to cultured 
salispheres.  
 
In summary, the effects caused by ligation/de-ligation to salispheres suggest that 
there is an association between the population of salispheres and salivary gland 
atrophy. The morphological similarities of salispheres between ROCKi and ligation 
experiments suggests that the Rho/A/ROCK might be one factor playing a role 
during atrophy, but also suggests that it is a complex mechanism and other factors 
















Neural input is important for mediating normal salivary gland secretion and salivary 
glands are innervated by both parasympathetic and sympathetic nerves. The primary 
neurotransmitters that mediate fluid secretion are acetylcholine and adrenaline and 
to a lesser extent neuropeptides (Proctor and Carpenter, 2007). Neuropeptides 
including calcitonin gene-related peptide (CGRP) and substance P (SP) target the 
main and small ducts as well as blood vessels. They are located in the sensory 
nerve fibers, which are carried by the parasympathetic and sympathetic nerve 
bundles (Kobashi et al., 2005; Ferreira and Hoffman, 2013) . It is known that CGRP 
coexists with SP in sensory neurons, which is present in all major salivary glands. 
The highest concentration of CGRP was found in the submandibular glands, and the 
highest concentration of SP was found in parotid and submandibular glands 
(Ekstrom et al., 1988). Both neuropeptides are involved in salivary secretion in rats 
and CGRP plays a role in the secretory response of SP (Ekstrom et al., 1984; 
Ekstrom et al., 1987; Ekstrom et al., 1988). In humans, levels of CGRP and SP are 
higher during salivary stimulation (Dawidson et al., 1997).  
 
Atropine inhibits salivary secretion by blocking muscarinic receptors and suppressing 
the release of SP (Yu et al., 1983). There are other neuropeptides such as 
substance K and vasoactive intestinal peptide (VIP), which are also involved in 
evoking salivary secretion (Ekstrom et al., 1983; Ekstrom, 1987). Here, only CGRP 





The role of parasympathetic nerves in fluid secretion through releasing acetylcholine 
led to the use of botulinum toxin for treating hypersalivation from nerves (Cordivari et 
al., 2004; Patel and Hoffman, 2014). This toxin blocks the release of acetylcholine 
(Cordivari et al., 2004). The use of botulinum has inhibited salivary secretion in cats 
resulting in xerostomia (Dickson and Shevky, 1923). Unlike atropine, botulinum toxin 
has a lasting effect and is thought to be a possible treatment for hypersalivation 
when using the appropriate dose (Bushara, 1997).  
 
Botulinum toxin was initially used for treating strabismus and dyskinesias of skeletal 
muscles as well as Frey’s syndrome (Scott, 1981; Laskawi et al., 1994; Drobik and 
Laskawi, 1995).  
 
Botulinum toxin is a 150 kDa metalloprotease, which is produced by Clostridium 
botulinum and comprises of heavy and light chains (Figure 5.1)  (DasGupta and 
Sugiyama, 1972; Simpson, 1980). There are eight immunological serotypes of 
botulinum: A, B, C1, C2, D, E, F and G (Blitzer and Sulica, 2001).  
 
 
Figure 5.1 Botulinum toxin structure. It is composed of light chain bound to one zinc atom 
and a heavy chain with a disulfide bridge [Modified from (Brin, 1997)].  
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Botulinum toxin type A (BonT/A) is most commonly used among the different 
serotypes because it is able to cleave synaptosomal-associated protein (SNAP-25) 
subunits (Brin, 1997). The mechanism of action of the neurotoxin relies on two main 
steps. The first step is the parent cleavage of the chain resulting in a heavy chain 
bound to a disulfide bond (around 100 kDa) to a light chain that is bound to one atom 
of zinc (around 50 kDa) (Schiavo et al., 1992). Three steps are then required for 
mediating paralysis: 1) internalization, 2) reduction and translocation of the disulfide 
to the cytosol and 3) the inhibition of neurotransmitters release (Brin, 1997).  
In the case of salivary glands, the action of botulinum relies on inhibiting the release 
of presynaptic acetylcholine (Sollner et al., 1993). Thus, a depression of the 
parasympathetic-dependent secretory function occurs as a consequence of the 
acetylcholine inhibition (Capaccio et al., 2008). It also can modify the concentrations 
of enzymes and solutes of saliva such as amylase (Ellies et al., 2002; Ellies et al., 
2004).  
 
In the previous chapter, ligation/de-ligation appeared to affect the culture of 
salispheres in vitro. In this study, the inhibition of the neural input in vivo and in vitro 
was included to determine the role of neural influence during salisphere 
development, and most importantly, to explore whether neural aberration would lead 
to similar effects to grown salispheres from injured glands.  
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5.2 Materials and methods 
5.2.1 Experimental design 
The experiments were divided into two categories; in vivo and in vitro experiments.  
 
In vivo: Mice were anaesthetized, as described previously, with ketamine/xylazine 
and injected with 0.5 U of BoNT/A into the right Wharton duct leading to the 
submandibular gland.  The left glands (contralateral glands) were injected with 
saline. Seven days later, under terminal anaesthesia, the submandibular glands 
were dissected, weighed, and processed for protein analysis, morphometric 
assessments and salispheres culture. The diagram below summarizes the 
experiments that have been carried out in this chapter: 
 
Figure 5.2 Diagram showing the experimental design for the in vivo study of BoNT/A 
injections. 
 
In vitro: Salispheres were cultured with different neuropeptides (SP and CGRP) and 
atropine. The morphology of salispheres and their protein expression, were 
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assessed at different time-points. Figure 5.3 shows the experimental design for the 
in vitro experiments: 
 
Figure 5.3 A diagram illustrating the in vitro experimental plan for salispheres 
treatment with different neuropeptides and atropine.  
 
5.2.2 BoNT/A injections 
For BoNT/A experiments, cannulation of the submandibular glands via the Wharton 
duct was preformed according to Kurki et al. (2011) protocol. The mouse was firstly 
anesthetized with xylazine (5 mg)/Kg)/ketamine (25 mg/Kg) i.p injections and 
positioned ventrally. Then, the maxillary incisors were locked by a metal wire and the 
mandibular incisors were hooked by an elastic string in order to keep the mouth 






Figure 5.4 The cannulation of the submandibular gland duct. The cannulation of the duct 
requires locking the maxillary incisors by a metal wire and hooking the mandibular incisors 
by an elastic string. 
 
Next, an insulin syringe with a 29G needle was placed into a 0.58 diameter 
polyethylene tube. The polyethylene tube was inserted approximately 5 mm inside 
the duct. 
 
Figure 5.5 An image of a 0.58 diameter polyethylene tube placed into a 29G needle of 
an insulin syringe.  
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An injection of 0.5 U of BoNT/A (Allergan, USA) in 50 µl of saline containing around 
2 µl of trypan blue was injected into the duct of submandibular gland. Pressure was 
retained on the piston for few minutes after injection, to avoid any backflow of the 
infusion. The mouse was kept in the incubator and was monitored until it recovered 
from the anaesthesia. Seven days post-injection, mice were terminally anesthetized 
with an overdose of pentobarbitone. The submandibular glands were dissected and 
weighed before further analysis.  
 
5.2.3 Isolation and culture of salispheres from BoNT/A injected 
glands 
The isolation and culture of salispheres from BoNT/A treated glands were carried out 
according to the protocol in section 2.2, and glandular weights were taken into 
consideration as only one gland was used for BoNT/A injections. The MTS viability 
assay was performed at day 4 of culture as described in section 2.10. In addition, the 
number and size of salispheres were counted, and the size of the salispheres was 
measured at day 4, as described previously in sections 2.3 and 2.5. Salispheres 
were collected at day 4 of culture as explained in section 2.6. 
 
5.2.4 Neuropeptides and atropine in vitro treatments 
Cells were directly treated prior to culture with CGRP, SP and atropine. Table 5.1 
shows the concentrations of CGRP, SP and atropine used in the salisphere culture 






CGRP 1 µM 
SP 10 µM 
Atropine 10 µM 
Table 5.1 Concentrations of neuropeptides and atropine applied in 1 ml of culture 
media. 
 
At day 4 and 8 of culture the salispheres were counted and the size of salispheres 
was measured, as described in sections 2.3 and 2.5.  
 
5.2.5 Gel electrophoresis and immunoblotting 
All salispheres and tissue samples were separated by SDS-PAGE and run under 
reducing conditions. Equal amounts of protein were loaded for tissue samples, 
whereas equal volumes of salisphere samples were loaded for gel electrophoresis.  
 
5.2.6 Antibodies 

















Cell signaling, UK 
    
Table 5.2 Antibodies which have been used in chapter 5 
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All Immunoblots were probed overnight including p-4e-bp1 and p-S6 rp antibodies as 
described previously in section 2.8.   
 
5.2.7 Tissue collection and homogenization  
Tissues were collected and homogenized as previously described in sections 2.12 
and 2.13. 
 
5.2.8 Protein concentration quantification 
Protein concentrations of controls and BoNT/A treated tissue homogenates were 
quantified by the BCA assay as explained in section 2.14.  
 
5.2.9 Periodic Acid Schiff’s staining and Coomassie Brilliant 
staining  
Gels were processed for Periodic Acid Schiff’s staining and Coomassie Brilliant 
staining as described in sections 2.15 and 2.16.  
 
5.2.10 Tissue sectioning and histochemical staining 
The procedure of tissue sectioning and histochemical staining of controls and 
BoNT/A treated submandibular glands were carried out according to the protocol 
described in section 2.17.  
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5.2.11 H&E staining 
Tissue sections were morphologically assessed by H&E staining as explained in 
section 2.18.  
 
5.2.12 Immunohistochemistry 
Tissue sections were stained with Caspase-3 (R&D systems, UK) antibody at a 
dilution of 1:300, to investigate the presence of apoptosis after BoNT/A treatment. The 
staining protocol is explained in section 2.20.  
 
5.2.13 Statistical analysis 
For BoNT/A experiments, unpaired two tail t-test was performed. Data acquired from 
the in vitro experiments were analyzed by one-way ANOVA followed by Tukey’s 
multi-comparison test, as described in section 2.21.  
 125 
5.3 Results  
 
5.3.1 Glandular weights 
After seven days of BoNT/A injections, glandular weights were directly measured 
after dissecting the glands. Statistically, there was no difference between the 
glandular weights of BoNT/A injected glands (57.75±3.52, n=4) and the glandular 
weights of controls (58.81±0.47g, n=4) (Figure 5.6).  
 
Figure 5.6 Mean gland weights. The mean gland weights of control glands and BoNT/A 




5.3.2 Cleavage of SNAP-25 demonstrated successful drug delivery 
to the glands 
The use of cleaved SNAP-25 antibody helped in determining the action of BoNT/A in 
the glands. A visible second band appeared (Figure 5.7) only in BoNT/A treated 
glands whereas only one band appeared in the control.  
 
Figure 5.7 Cleaved SNAP-25 expression levels in control and BoNT/A injected glands. 
The second band represents cleavage of SNAP-25, which occurred only in BoNT/A injected 
glands, n=4.  
 
5.3.3 Effects of BoNT/A injections biochemical and histological 
analysis 
To determine the effects of BoNT/A on the glands, mucin levels were measured by 
the PAS staining. BoNT/A treated glands showed similar levels of mucins to controls 
(Figures 5.8, A and B). In addition, total protein levels analyzed using Coomassie 

















Figure 5.8 Mucin and total protein levels from BoNT/A treated submandibular glands. 
A) Periodic Schiff’s staining and B) Coomassie staining of gland homogenates of untreated 
glands and seven day treated submandibular glands with 0.5U BoNT/A. C) Relative levels of 




Figure 5.9 H&E staining and immunohistochemistry of caspase-3 and of untreated and 
BoNT/A treated submandibular glands. Upper panel indicates histological appearance of 
acinars and ducts of control (untreated glands) and BoNT/A injected glands. BoNT/A 
injections did not show distinctive effects on histology of submandibular glands, except some 
enlarged blood vessels were observed post-injection (black arrow). Lower panel indicates 
immunohistochemistry of control (untreated) and of BoNT/A treated tissue sections which 
showed weak staining against caspase-3 in BoNT/A treated glands and mostly appeared in 
(black arrow) ducts, whereas control glands were almost negative against capsase-3. The 
scale bar represents 20 µm.  
 
In addition, acinars and ducts appeared unaffected by BoNT/A as H&E staining 
showed similar morphology to controls. However, immunohistochemical staining of 
caspase-3 demonstrated some apoptotic bodies in BoNT/A treated glands. Although, 
the staining was weak, caspase-3 was mostly detected in the ducts (Figure 5.9).  
H&E  H&E  
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5.3.4 The action of BoNT/A did not abolish salispheres formation in 
vitro 
Isolating and culturing salispheres from injected glands with BoNT/A, showed similar 
behavior of cultured salispheres from a normal healthy gland. Both, MTS levels 
(p=0.2624) (Figure 5.10, B), number of salispheres (p=0.1020) (Figure 5.10, C) and 
size of salispheres (Figure 5.10, D) at day 4 of culture exhibited no statistical 
differences compared to controls. Interestingly, BoNT/A injections caused the 


















Figure 5.10 Effects of BoNT/A on culture of salispheres. A) Images of developing 
salispheres at day 4 of culture from untreated glands and those derived from gland injected 
with BoNT/A. B) Absorbance values of MTS viability assay showed no impact occurred post 
BoNT/A injections. C) Salispheres numbers were comparable to controls as well as D) area 




5.3.5 Effects of neuropeptides	  and	  atropine	  showed	  on	  salispheres	  
culture	  
To evaluate the effects of neural input and inhibition in vitro, salispheres were 
cultured from day 0 with the neuropeptides CGRP and SP, as well as atropine, which 
is an inhibitor of parasympathetic cholinergic signalling. 
 
Generally, the neuropeptide treatment did not affect the formation of salispheres or 
affect their culture at days 4 and 8 of culture, as the number and size of the 
salispheres were comparable to controls. However, only atropine caused a 
significant decline in number of salispheres at day 4 of culture (Figures 5.11, A, B 
and C). Conversely, mTOR expression appeared unaffected by the treatments as 
the phosphorylation of 4e-bp1 and S6 rp was comparable to the untreated 
salispheres (Figure 5.12).  
 
As p-ERK is associated with the activation of CGRP and SP, the phosphorylation of 
ERK was measured at day 8 of salisphere culture, treated with neuropeptides and 
atropine. The expression of p-ERK clearly appeared in SP treated salispheres, but 




Figure 5.11 Morphological assessment of salispheres after 4 and 8 days of culture 
with CGRP, SP and atropine. A) Images of salispheres at day 4 of culture in the presence 
of neuropeptides and atropine (*p<0.05). B) Salisphere numbers were significantly reduced 
after atropine treatment. C) Area size of all cultured salispheres was comparable to controls. 
D) The number of atropine treated salispheres recovered by day 8 of culture. E) However, 
the mean area size of neuropeptide and atropine treated salispheres was significantly 











Figure 5.12 mTOR levels in neuropeptide and atropine treated salispheres at day 4 of 
culture. A) Immunoblot of salisphere lysates probed with p-S6 rp, p-4e-bp1 and β-actin. 
Both the B) relative expression of 4e-bp1 and C) S6 rp reflect no differences in mTOR 






Figure 5.13 p-ERK expression in neuropeptide and atropine treated salisphere lysates. 
Blot represents of two experiments and presented as preliminary evidence only.   
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5.4 Discussion  
BoNT/A is commonly used to reduce salivary secretion in hypersalivation disorders. 
In addition, BoNT/A has shown a protective role against radiotherapy-induced 
damage to salivary glands (Teymoortash et al., 2009). These experiments were 
designed to understand the effects of BoNT/A on gland and progenitor cell culture 
because BoNT/A is correlated with the suppression of salivary secretion. My 
objective in this chapter was to correlate the effects caused by injury on salispheres 
(Chapter 4), to the inhibition of neural input on to salispheres, to reveal how the 
autonomic nerve supply could be important for glandular regeneration (Osailan et al., 
2006b). 
 
The inhibition of salivary secretion by BoNT/A is time and dose-dependent (Xu et al., 
2015). Most studies using rat and rabbit have applied BoNT/A by intraglandular 
injections (Ellies et al., 1999; Shan et al., 2013; Xu et al., 2015). In this study, the 
cannulation procedure was chosen to insure a uniform delivery of BoNT/A into the 
gland. The difficulty of this process was to avoid any backflow of the infusion due to 
the pressure. 
 
In these experiments, the seven days injections of BoNT/A caused no difference on 
gland weights, similar to findings in rabbits (Figure 5.6)  (Shan et al., 2013). Since 
BoNT/A directly affects the cleavage of SNAP-25, the detection of cleaved SNAP-25 
is an indication of BoNT/A delivery and action (Figure 5.7). In rat experiments the 
cleavage of SNAP-25 at neuroglandular junctions occurred within seven days of 
injection (Xu et al., 2015). Interestingly, the SNAP-25 was also cleaved in the 
contralateral glands, suggesting that a leakage of BoNT/A might occurred., for this 
reason the contralateral glands were excluded from this study.  
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As SNAP-25 was cleaved by BoNT/A, further analysis was performed to detect 
possible biochemical and histochemical changes to the salispheres before and after 
BoNT/A administration. Protein analysis revealed that mucin and total protein levels, 
and histology, were unaffected by the toxin (Figures 5.8, A and B). However, cleaved 
SNAP-25 and evidence of apoptosis suggest that the injections affected the glands 
without causing atrophy (Figure 3.8, C) (Coskun et al., 2007).  
 
Similar to these findings, previous investigations have shown that BoNT/A induces 
apoptosis, but other studies did not observe apoptosis nor changes in acinar cell 
volume or lymphatic infiltration (Figure 5.9) (Ellies et al., 1999; Ellies et al., 2000; 
Coskun et al., 2007; Shan et al., 2013). Presumably, the delivery technique used 
might affect the apoptotic level without causing morphological damage, because an 
intraglandular injection of a concentrated amount of BoNT/A, in a defined area, could 
cause more stress and toxicity.  
  
In contrast to salivary gland atrophy, the ability to isolate and culture salispheres post 
BoNT/A injections suggest that suppressing parasympathetic innervation would not 
affect the progenitor pool. This observation also suggests that parasympathetic 
innervation acts differently on an irradiated or ligated glands.  However, the 
adherence property of cultured salispheres occurred at day 6, suggesting that 
attachment was likely driven by minor parasympathetic inputs.  
 
As parasympathetic nerves play a role in regeneration, in vitro experiments of CGRP 
and SP were also included (Proctor and Carpenter, 2007). During denervation of 
salivary glands, both CGRP and SP were down regulated around the salivary gland 
ducts (Gibson et al., 1984; Soinila et al., 1989). Moreover, ductal ligation causes 
 137 
salivary gland atrophy and decreases SP release (Ekstrom et al., 1984). As 
sympathectomy causes an increase in CGRP and SP levels in both parotid and 
submandibular glands, in vitro experiments of CGRP, SP and atropine were included 
to investigate if neuropeptide stimulation and inhibition affected the characteristics of 
salispheres in vitro (particular adhering to the plastic dish). 
  
The use of neuropeptides has not mimicked the action of BoNT/A treatment on 
salisphere formation. Although, statistically there were no differences due to the 
treatments, previous studies have shown that continuous stimulation of 
neurotransmitters can damage cellular function, which might explain the minor 
effects on salisphere size at a late stage of culture (day 8) (Horie et al.,1996). In 
addition, mTOR expression in treated salispheres was unaffected by neuropeptide or 
atropine treatment, emphasizing that mTOR is more likely to be responsible for 
salisphere growth. 
 
Neuropeptides including CGRP and SP are associated with the activation of the 
extracellular signal-regulated kinase (ERK) (Parameswaran et al., 2000; Lallemend 
et al., 2003). In the present study, phosphorylation of ERK occurred in untreated 
salispheres, and the inhibition of ERK phosphorylation by atropine suggests that 
normal salispheres might contain endogenous neuropeptides. Under these 
conditions, SP showed a greater effect on ERK expression compared to CGRP 
treated salispheres, suggesting that the phosphorylation of p-ERK is principally 
stimulated by SP. 
 
In conclusion, the in vivo and in vitro experiments suggest that neural suppression 
did not considerably affect the characteristics of salispheres. Although, the minor 
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effect caused by BoNT/A to form salispheres suggests that neural alterations might 












6 TRANSPLANTATION OF MODIFIED SALISPHERES INTO 
SALIVARY GLANDS 
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6.1 Introduction  
Radiotherapy can cause irreversible salivary dysfunction and loss. Specifically, 
irradiation negatively affects saliva flow rate, gland weight and acinar cell numbers 
(Burlage et al., 2001; Coppes et al., 2009). In addition, it causes cellular damage 
such as apoptosis, which occurs post-radiation (Vissink et al., 1990; Paardekooper 
et al., 1998).   
 
Recently, stem cell transplantation into damaged salivary glands has been widely 
investigated as a method to rescue salivary glands from damage. In 2006, Lombaert 
et al. found that transplantation of BMCs into an irradiated gland was able to improve 
salivary function and morphology (Lombaert et al., 2006b). However, limited access 
to BMCs led to the discovery of salivary gland stem/progenitor cell transplantation 
(Lombaert et al., 2008a).  
 
Different stem cell marker expressing cells such as CD49f, CD133, and c-kit have 
been transplanted into irradiated glands. All of these transplanted cell expressing 
markers have improved saliva production. However, the isolation and transplantation 
of c-kit expressing cells into irradiated glands has shown to be the most effective for 
gland recovery, compared to other stem cell expressing markers, which require 
higher cell numbers for successful regeneration (Lombaert et al., 2008a; Feng et al., 
2009; Nanduri et al., 2013,). Conversely, ligation of the main excretory duct induces 
atrophy, which is characterized by apoptosis and acinar cell loss (Shiba et al., 1972; 
Takahashi et al., 2000). The removal of the obstruction allows the glands to 
regenerate and functionally recover. In other studies, morphological and cellular 
regeneration markers are upregulated after three days of de-ligation. The expression 
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of perinatal proteins in the immature acinar cells during de-ligation suggest 
regeneration occurs via an embryonic/prenatal pathway (Cotroneo et al., 2008). 
 
The degree of glandular recovery is time-dependent on the length of ligation. For 
example, in rats, 8 weeks of de-ligation allows acinar cells to appear normal, yet the 
acinar cells were smaller than acinar cells of a normal gland (Osailan et al., 2006a). 
However, in other studies on other species showed that full recovery appeared after 
seven days of de-ligation (Bhaskar et al., 1966). It has been also previously reported 
that longer periods could result in full recovery of acinar cells (Tamarin, 1971a). 
 
Growth factors and signalling pathways previously investigated which have shown to 
be involved in the protection of salivary glands against damage (Lombaert et al., 
2008b; Hai et al., 2012; Hai et al., 2014). For this reason, it would be interesting 
translate the in vitro effects of several inhibitors such as rapamycin, LiCl and ROCKi 
to the in vivo behavior of salivary glands.  
 
Indeed, salivary gland regeneration is a promising field for ameliorating radiation 
induced salivary gland damage. In this chapter, this possible treatment was explored 
by injecting treated salispheres with selected inhibitors, including rapamycin, LiCl, 
ROCKi, into normal salivary glands. These molecules and their combinations have 
shown exciting and distinctive effects on salisphere characteristics and therefore 
were selected for the following in vivo study. 
 
Work has been performed so far on normal salivary glands to explore technical 
experimental approaches and to evaluate the physiological response of salivary 
glands to injections. In addition, intraglandular injections of treated salispheres have 
 142 
been performed once in de-ligated glands to compare the ability of these injections 
of recovering damaged gland. Future studies on damaged glands would confirm 
whether these injections would encourage regeneration and the recovery process.  
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6.2 Materials and methods  
 
6.2.1 Experimental design 
In this chapter, normal submandibular glands were injected with salispheres that had 
been treated with selected inhibitors from previous experiments. Only one de-ligation 
experiment was performed for each salisphere injection. At the end of each 
experiment, glands were collected for biochemical and histochemical analysis.  
 
6.2.2 Isolation and culture of salispheres 
The isolation and culture were processed according the protocol described in section 
2.2. The cells were treated with several inhibitors at day 0 of culture. Table 6.1 
shows the concentrations of the inhibitors, which have been used in this chapter: 
 
Inhibitors Concentrations 
LiCl 10 mM 
Rapamycin and LiCl 
(Rapa+LiCl) 
Rapa 22 nM 
LiCl 10 mM 
ROCKi 10 µM 
  






6.2.3 Salisphere counting 
At day 4 of culture, salispheres were counted as previously described in section 2.4. 
Around 1,000 spheres were used for the intraglandular injections.  
6.2.4 Salisphere preparation 
After four days of culture with the inhibitors, salispheres were incubated for 15 
minutes with 1 µl of vybrant cell labeling solution. Salispheres were then pelleted at 
400 g for 5 minutes and re-suspended with 200 µl of DMEM-F12 media. 
 
6.2.5 Salisphere injections into normal and de-ligated 
submandibular glands  
Mice were anaesthetized as previously descrived. A 0.5 cm skin incision was made 
in the centre of the neck. A blunt dissection was performed where the fat surrounding 
the salivary glands were dispersed and the salispheres were injected using a 26G 
needle into different areas of the glands. The mice were allowed to recover from the 
anaesthesia. After seven days, the mice were terminally anaesthetized with an 
overdose of pentobarbitone.   
 
For salisphere injections into de-ligated glands, the submandibular gland ducts were 
ligated for seven days using a clip, skin was sutured and mice were allowed to 
recover from the anesthesia. Following seven days of ligation, de-ligation was 
processed for additional week. De-ligation and salisphere injections were carried out 
by the removal of the clip, followed by a direct injection of the salispheres into the 
glands. The skin then was sutured and the mice were allowed to recover from the 
anesthesia. Mice were terminally anesthetized after seven days of de-ligation.  
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At the end of all experiments the submandibular glands were collected and glands 
weights were measured before further analysis. 
 
6.2.6 Tissue collection and homogenization  
Tissues were collected and processed for homogenization as described previously in 
sections 2.12 and 2.13. 
 
6.2.7 Protein concentration quantification  
Protein concentrations were determined using the BCA assay as previously 
explained in section 2.14.  
 
6.2.8 Immunoblotting 
Equal amounts of proteins were processed for gel electrophoresis and 
immunoblotting as described in section 2.17. 
 
6.2.9 Coomassie Brilliant Blue staining 
Gels were used for protein staining with Coomassie Brilliant staining as described in 
section 2.16. 
 
6.2.10 H&E staining and morphometric assessment 




6.2.11 Statistical analysis 
Statistical assessment was performed by one-ANOVA and Tukey’s test as described 
in section 2.21.  
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6.3 Results  
 
6.3.1 Gland weight assessment 
The glandular injections of treated salispheres with rapamycin, LiCl, ROCKi, and co-
treatment of rapamycin and LiCl resulted in slight, but statistically insignificant, 
increases in gland weights (p=0.2562) (Table 6.2) (Figure 6.1). In addition, no 
differences were observed in gland weights of regenerated glands caused by the 
injection, yet a slight increase was observed in injected regenerated gland with LiCl 
treated salispheres (Table 6.3) (Figure 6.5).  
 
Intraglandular injections of treated 
salispheres with different inhibitors 
 
Gland weights (mg) 
Control glands 60.37 ± 2.02, n=3 
Control injected glands 77.00 ± 10.17, n=3 
LiCl injected glands 79.03 ± 6.46, n=3 
ROCKi injected glands 70.87 ± 3.27, n=3 
Rapa+LiCl injected glands 72.37 ± 2.82, n=3 
  
Table 6.2 Mean weight of submandibular glands after seven days of Intraglandular 





Figure 6.1 Mean submandibular gland weights. Injections of untreated salispheres 
(control inj). LiCl treated salispheres (LiCl inj), ROCKi treated salispheres (ROCKi inj) 
rapamycin and LiCl treated salispheres (Rapa+LiCl inj) into normal submandibular glands 
shows no significant effects on gland mass. 
 
6.3.2 Coomassie staining showed some differences in total protein  
Protein distribution among the different treatments was variable. The injection of 
treated salispheres with LiCl showed similar a protein pattern compared to the 
injection of untreated salispheres into the submandibular glands. While the injection 
of ROCKi treated salispheres and rapa+LiCl treated salispheres in submandibular 
glands demonstrated a more intense pattern of protein content compared to the 




Figure 6.2 Total proteins detected by Coomassie blue staining of SDS-PAGE gels of 
submandibular gland homogenates. The ROCKi and rapa+LiCl showed a greater 
abundance of proteins compared to the control (band 3 and band 5), whereas minor mucin 
levels (band 4) appeared unchanged. Intranglandular injected glands with rapa+LiCl treated 
salispheres showed a complete lack of band 1.  
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6.3.3 Histological analysis post-treatment 
Immunohistochemical analysis showed that injections did not cause significant 
damage to the glands. Neither injections of salispheres into normal glands (Figure 
6.3) nor regenerated glands (Figure 6.7) affected their histology. Although injections 
of healthy salispheres showed a slight increase in acinar cell volume. However, the 
effects of all injections on acinar cell volume was insignificant (Figure 6.3) on both 




Figure 6.3 H&E and morphometric analysis of injected submandibular glands with 
salispheres. Images representing histological appearance of salivary glands after 
salisphere’s intraglandular injections. Generally, no significant histological differences 
caused by the different treatments. The morphometric analysis showed a slight increase in 
the area size of the acini of injection with untreated salispheres and LiCl treated salispheres. 
The bar represents 20 µm. 
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6.3.4 Salispheres injections induce mTOR activation  
To determine if mTOR is activated due to the intraglandular injections of salispheres 
into normal glands, immunoblots of tissue homogenates were probed with p-4e-bp1 
and p-S6 rp. The injections of treated salispheres demonstrated that p-4e-bp1 is 
expressed in all samples. However, the phosphorylation of S6 rp only appeared in 
injected glands with ROCKi treated salispheres (Figures 6.4, B and 6.8).  
 
Conversely, the intraglandular injections of untreated salispheres, LiCl treated 
salispheres, ROCKi treated salispheres and the co-treatment of rapa+LiCl 
salispheres into a regenerated gland showed an expression of S6 rp in all samples 





Figure 6.4 Effects of intraglandular injections of salispheres on mTOR activity. A) 
mTOR status in muscle from mouse biceps fermoris (positive control) and in mouse 
submandibular gland (negative control). B) Intraglandular injections appeared to 
phosphorylate 4e-bp1, while only ROCKi to affected both mTOR substrates, n=3.  
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6.4 Discussion 
In vitro experiments of cultured salispheres with several inhibitors showed distinctive 
effects on salispheres culture including salisphere survival and adhesion. The 
injection of in vitro treated salispheres with several inhibitors into normal salivary 
glands was firstly performed to explore their physiological response to different 
injections.  
 
Previous studies have used dissociated cells rather than salispheres for 
intraglandular transplantation of salivary gland progenitor cells (Lombaert et al., 
2008a; Nanduri et al., 2013). However, in these experiments, salispheres were 
injected directly into the glands without dissociating them into single cells. The 
purpose for applying this method was to avoid any treatment attenuation upon 
salisphere dissociation. Another, reason was that expressing cell specific markers 
such as c-kit was not taken into consideration.  
 
In addition, the effects of intraglandular injections of salispheres into de-ligated 
glands were determined (shown in Appendix A). This would help in exploring if any 
of these inhibitors could assist the gland recovery. However, this preliminary 
experiment was carried out only once due to pressure and atrophy caused by injury. 
Further optimization is required to minimize the variability caused by the injection 
and injury.  
 
Although a slight increase in gland weight was observed post-injection, 
intraglandular injections of treated salispheres into normal submandibular glands the 
physiology of the glands, that is, the protein content, size of acini and histology 
appeared normal. This suggests that the injections generally did not negatively affect 
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the gland. However, the injection of LiCl treated salispheres into a regenerated gland 
resulted in the glandular weight recovery, because the gland weight was comparable 
an un-operated gland. A previous study demonstrated that glandular recovery 
increases by 50% after seven days of removal of obstruction. This suggests that the 
injection of LiCl treated salispheres into an injured gland could enhance the recovery 
by 30% compared to untreated de-ligated glands (Cotroneo et al., 2010).  
 
LiCl is a GSK-3 inhibitor, which is involved in regulating both mTOR and Wnt. 
Normal homeostasis of haematopoietic stem cells requires mTOR and Wnt, where 
Wnt is involved in self-renewal and mTOR is involved in differentiation, thus 
regulating normal homoeostasis (Huang et al., 2009). This suggests that LiCl acted 
on both mTOR and Wnt resulting in in vivo recovery via the asymmetric division of 
the stem/progenitor pool (Coppes et al., 2009). This also suggests that the 
mechanism of action of LiCl in vivo is Wnt mediated, because a study showed that 
Wnt induced in progenitor cells transplantation helped in the recovery of normal 
homoeostasis (Maimets et al., 2016). However, functional analysis is required to 
confirm these findings.  
 
In normal conditions, salivary glands undergo tissue cell loss due to aging, for this 
reason compensation is required to maintain tissue homeostasis. The compensation 
includes proliferation and differentiation of the progenitor cells (Coppes and 
Stokman, 2011). 
 
Interestingly, mTOR activation in injected glands implies that signalling alterations 
occurred due to the injection, as all samples (salispheres injection into normal and 
regenerated glands) appeared to express either S6 rp or 4e-bp1. However, the 
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phosphorylation of both substrates of mTOR after the injection of ROCKi treated 
salispheres might indicate that ROCK is associated with mTOR and atrophy.  
 
In conclusion, the effect of LiCl on a regenerated gland suggests that it might be a 
good tool for glandular recovery through salispheres. In addition, the effect of ROCKi 
on activating both mTOR substrates in normal glands and a regenerated gland 
suggest that there is a correlation between mTOR and ROCK. However, further 
investigations are required to discover the effect of these injections on glandular 
recovery post-injury. Moreover, further analysis is required to understand the 
mechanism, the safety of these injections and to confirm if LiCl could support 
















The characteristics of salivary gland stem/progenitor cells have been well 
established by LRC and regeneration studies, proving their existence in the ductal 
compartment (Denny et al., 1993; Man et al., 2001; Kimoto et al., 2008), and 
highlighting the importance of the stem/progenitor pool for normal salivary gland 
tissue homeostasis (Pringle et al., 2013). 
 
In addition, they are a promising therapeutic tool for repairing salivary glands after 
damage. Regeneration studies of salivary glands include ligation/de-ligation or 
transplantation of salivary gland stem/progenitor cells into an irradiated gland, 
demonstrated the ability of salivary gland to regenerate (Cotroneo et al., 2010). 
Transplantation of cells expressing specific stem cell markers such as c-kit into 
damaged glands clearly illustrated the regenerative potential of salivary glands 
(Lombaert et al., 2008a; Feng et al., 2009; Pringle et al., 2016; Nanduri et al., 2011). 
Additionally, the administration of growth factors or the activation of specific intrinsic 
signalling networks such as KGF and Wnt, have also shown a role in stimulating 
glandular repair post-radiation (Lombaert et al., 2008b; Hai et al., 2012).  
 
Signalling networks are involved in numerous cellular processes. Specifically, the 
mTOR signalling pathway is involved in several roles such as protein synthesis, cell 
proliferation and differentiation (Laplante and Sabatini, 2012a) The translational 
machinery is regulated by mTOR and as previously stated, the cooperation of 4e-
bp1 and S6 rp are responsible for initiating translation, and subsequently regulating 
cell growth and protein synthesis in both normal and disease states (Howell et al., 
2013). One of the main objectives of this project was to explore the in vitro effects of 
mTOR inhibition on salisphere growth and culture. Another objective was to 
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investigate the in vivo response of salivary glands to intraglandular injections of 
inhibitor-treated salispheres on glandular recovery. In culture, the salivary gland 
stem/progenitor population pool is limited, and therefore a further objective was to 
determine if mTOR stimulation would increase the number of salispheres. Therefore, 
assessing mTOR activity in developing salispheres was an essential step before 
understanding the differences between growing salispheres from normal and injured 
glands.  
 
Several upstream factors promote mTORC1 complex activity, including growth 
factors and insulin (Martin and Hall, 2005; Huang and Fingar, 2014,). The binding of 
EGF to cell surface tyrosine kinase receptors subsequently activates mTOR through 
the MAPK kinase (Huang and Fingar, 2014). In contrast to normal salivary glands, 
which lack mTOR activity, mTOR is activated during salisphere development from 
both normal and injured ligated glands. The activation of mTOR in salispheres 
suggests that the growth media contains sufficient insulin and growth factors to 
activate mTOR. In addition, data from rapamycin experiments demonstrated the 
necessity of mTOR for salisphere growth and survival, and subsequently their 
regeneration (Fingar et al., 2002).  
 
Compensatory hyperplasia during ligation is accompanied with ductal and acinar cell 
proliferation (Walker and Gobe, 1987). In this present study, the increased number of 
salispheres in contralateral glands during ligation may be a compensatory 
hyperplasia, driven by the stem/progenitor cell population. Although, the mechanism 




Cross talk between mTOR and Wnt was demonstrated by the action of LiCl on 
salisphere formation and development. In vitro experiments showed exciting effects 
of LiCl on salisphere morphology including size increases and the prevention of 
branching within the collagen/matrigel matrix. It is hypothesized that in a similar 
culture system, the size of neurospheres reflects their developmental maturity in 
response to growth factors such as EGF and FGF, as well as the proliferation and 
differentiation status of these stem/progenitor cells (Suslov et al., 2002). However, 
the LiCl treated salispheres preserved their spherical structure in vitro, suggesting 
that the stem/progenitor cells were too naïve to respond to EGF/FGF signals. Only 
by in vivo transplantation might help in assessing the regeneration significance.  
 
Organoid formation is an indicator of successful differentiation as shown in previous 
studies and in this study (Feng et al., 2009; Maimets et al., 2016; Lombaert et al., 
2017). As normal healthy salispheres are able to form acinar-ductal like structures in 
a collagen/matrigel matrix, this suggests that mTOR may be responsible for this 
process. Also, LiCl-treated salispheres preserve their spherical clusters, which 
implies that LiCl through stimulating Wnt prevents the formation of acinar-ductal like 
structures. Previously, it was demonstrated that mTOR inhibition and Wnt activation 
is important for maintaining hematopoietic stem cells (Huang et al., 2012). However, 
in the case of salispheres, the dual treatments of LiCl and rapamycin affected their 
primary survival.  Hence, this would strongly suggest that mTOR and Wnt are both 
important factors for in vitro culture of salispheres.  
 
The exciting finding of adherent salispheres from ligated/de-ligated glands suggests 
that salisphere growth was altered by injury. The impairment of cytokeratins and 
protein expression of signalling pathways due to irradiation suggests that this might 
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be correlated to the morphological changes observed in salispheres derived from 
injured glands (Nanduri et al., 2013). 
 
Since salispheres acquired a distinctive morphology, cytoskeletal rearrangements 
were initially suggested to be responsible for these changes. The second complex of 
mTOR and RhoA/ROCK signalling were selected to be investigated because they 
are both involved in cytoskeletal rearrangement. Morphological similarities, as well 
as the expression pattern of p-FAK and CK5 between ROCKi treated salispheres 
and grown salispheres from ligated glands, suggest minor alterations in ROCK 
signalling post-injury. While mTORC2 inhibition failed to show this phenotype. These 
data also imply that there are other factors behind the morphological alterations. 
 
It has been reported that ROCK inhibition plays a role in the survival of human 
embryonic stem cells and decreases apoptosis (Watanabe et al., 2007; Li et al., 
2009). In addition, ROCK inhibition may prevent salisphere senescence and 
enhance their expansion (Lee et al., 2015). Although, the proliferation of salispheres 
was stimulated by ROCKi, and similar to the study performed by Lee et al. the 
salispheres became adherent (cultured from un-operated gland). This suggests 
salisphere attachment is partly due to RhoA-ROCK signalling, and likely other 
unknown upstream signals. As ROCK inhibition showed some similarities to 
salispheres derived from injured glands, neural input may also play a role. 
 
Although, in vitro and in vivo experiments of involving BoNT/A, neuropeptides and 
atropine suggest that BoNT/A was minimally related to the morphological alterations 
of salispheres, and other factors may be responsible for these changes. The role of 
nerves in stem/progenitor cells behaviour was highlighted by a recent paper, which 
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showed that salivary stem/progenitor cells were unable to regenerate post-irradiation 
due parasympathetic alterations (Knox et al., 2013). Atrophy caused by ductal 
ligation with or without including the chorda lingual nerve in rats (extraoral duct 
ligation and intraoral ligation respectively) is reversible (Scott et al., 1999; Osailan et 
al., 2006b; Carpenter et al., 2007), suggesting a minor influence. However, the 
neural influence is important for salivary secretion, as a recent study showed that 
inhibiting SP resulted in the atrophy of the acinar cells (Hishida et al., 2016). 
Presumably, the parasympathetic denervation mode of action during ligation is 
different compared to the mechanism of BoNT/A, which illustrates the differences 
between salispheres derived from injured glands and BoNT/A injected glands 
(Emmelin, 1968; Coskun et al., 2007; Proctor and Carpenter, 2007). 
 
The stem/progenitor pool is localized in the ductal compartment. It is also presumed 
that if cell proliferation increases during injury, there would be no effect on the 
production of stem/progenitor cells in vitro. If regeneration could occur during 
ligation, the population of salispheres would not be affected as they represent the 
stem/progenitor cell pool. As regeneration models including salivary gland extirpation 
and ligation/de-ligation models have shown that extensive proliferation of ductal cells 
appear post-injury (Hanks and Chaudhry, 1971). However, the degree of obstruction 
is correlated with the level of ductal cell proliferation from residual and not actively 
proliferating ductal cells (Takahashi et al., 2000; Takahashi et al., 2004). In addition, 
it has been demonstrated that in the first period of ligation extensive ductal 
proliferation occurs, but at late period acinar cells apoptosis and fibrotic tissue are 
observed (Carpenter et al., 2007). Indeed, the reduction of salispheres post-injury 
could be apoptotic.  
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The protective role of mTOR within acinar cells could possibly imply that these acinar 
cells are involved in salispheres formation but not through acinar cell self-duplication 
(Silver et al., 2010; Aure et al., 2015). Another suggestion is that atrophy may drive 
these salispheres to differentiate as a consequence of the glandular activation of 
mTOR (Silver et al., 2010). In addition, the inhibitory effects of RhoA/ROCK could be 
correlated with differentiation, as observed in mouse neural stem cells (Gu et al., 
2013). While, the remaining salispheres during ligation may be responsible for the 
asymmetric division during regeneration, as removal of the obstruction results in the 
recovery of the gland and salisphere population (Kimoto et al., 2008; Coppes et al., 
2009). However, if progenitor cells undergo differentiation during atrophy, they may 
also undergo restrictive division driving differentiation (Coppes et al., 2009). The 
diagram below describes a possible mechanism based on stem/progenitor cells 










Figure 7.1 Asymmetric division and restrictive division. Asymmetric division is a process 
whereby a stem cell generates one daughter stem cell and one daughter multipotent 
progenitor cell. These two daughters produce a group of stem cells, multipotent progenitors 
and lineages restricted progenitors. Subsequently, these stem cells and progenitors are 
maintained, and are responsible for cellular differentiation. Restrictive division occurs in 
progenitor cells, which are more committed to producing differentiated cells only. Modified 
from Coppes et al., 2009.  
 
 
Since several inhibitors such as rapamycin, LiCl and ROCKi have shown various 
effects on the culture of salispheres, intraglandular injections of treated salispheres 
with these inhibitors were applied. The in vivo transplantation of salispheres would 
translate the in vitro effects of the inhibitors on glandular recovery. Before examining 
the impact of salisphere transplantation on glandular recovery on injured glands, the 
injections were applied to controls to understand the physiological response of 
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normal glands to the injections. Although the intraglandular injections of salispheres 
into regenerated glands have been performed once, LiCl and ROCKi showed some 
effects either on glandular recovery or mTOR activation. The output of LiCl on 
salispheres culture could possibly responsible for glandular recovery of a 
regenerated gland. Indeed, administration of LiCl has been shown to accelerate the 
repair and recovery of renal function (Bao et al., 2014). This suggests that LiCl could 
play a role in enhancing the recovery process.  
 
Salivary gland primary cell culture is heterogeneous (e.g parenchymal cells, neural 
cells), and expresses several stem cell markers (Coppes and Stokman, 2011). As 
the whole population will be transplanted it is difficult to distinguish which type of 
cells are responsible for the enlargement and recovery of the de-ligated gland. 
However, the in vivo effect of ROCK inhibition suggests that there is crosstalk 
between mTOR and ROCK. In addition, the activation of mTOR in salivary glands by 
ROCKi treated salispheres implies a connection between salivary gland atrophy and 
ROCK via mTOR signalling, as mTOR was activated during ligation (Silver et al., 
2010).  
 
In conclusion, mTOR is one of the important signalling networks for salispheres 
survival and development. The use of several inhibitors helped to identify several 
factors that may play a role in salisphere behaviour in healthy and injured glands.  
The exciting in vitro and in vivo effects of LiCl suggest that a GSK-3 inhibitor could 
stimulate salisphere growth and gland recovery presumably via Wnt and mTOR. In 
addition, the in vivo effects of ROCK inhibition suggest that ROCK signalling might 
be correlated to atrophy as it manipulated the characteristics of salispheres as well 
as glandular mTOR. However, further investigations are required to confirm these 
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findings, and to understand the molecular mechanism of intracellular signalling in 
salispheres during regeneration.  
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7.2 Future plan 
Although the results achieved from this PhD have shown some novel insights of the 
involvement of mTOR in regeneration, they also pose more questions to answer for 
potential future work in this field.  
 
• Transplantation of c-kit expressing cells into damaged glands has shown the 
ability of stem/progenitor cells to rescue salivary glands against damage 
(Lombaert et al., 2008a). Since	   In vitro experiments showed that LiCl has 
positively affected the culture of salispheres, it would be interesting to identify 
markers which are influenced by LiCl treatment.  
 
• Since the culture of salispheres from ligated glands behaved differently 
compared to normal healthy salispheres, it would be interesting to determine if 
salivary gland stem/progenitor cells from injured glands are undergoing 
differentiation in vitro. In addition, injections of adherent salispheres into 
injured glands would help in investigating the regenerative capacity of these 
stem/progenitor cells, and in determining the relationship between the 
adherent property and regenerative potential. 
 
• As ROCK inhibition showed some effects on mTOR activity and glandular 
mTOR is only activated during atrophy, glandular injections of ROCK inhibitor 
would help in answering if ROCK inhibition is associated with atrophy (Silver 
et al., 2010; Bozorgi et al., 2014). Further, culture of salispheres from injected 
normal glands with ROCKi would also assist in revealing whether 
RhoA/ROCK is impaired during ligation and responsible for alterations of 
salispheres (e.g. number, morphology) caused by ligation.  
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• Since the intraglandular injections showed variable effects on the total protein 
contents by Coomassie blue staining, it would be helpful to perform proteomic 
analysis, to explore which proteins are dysregulated post-injection.  
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APPENDIX A 	  	  
Injection of treated salispheres into a 
de-ligated gland 
Gland weights (mg) 
 



















Table 6.3 Gland weights of submandibular glands post-injection with untreated, LiCl, 













Figure 6.5 A graph representing the differences between weights of control, ligated, de-
ligated and the gland weight post injection with untreated, LiCl, ROCKi and rapa+LiCl 
salispheres into regenerated gland. Ligation (p=0.0002) and de-ligation (p=0.014) caused a 
significant decline in gland weight. Injections of treated salispheres into regenerated glands 
showed that only LiCl treated salispheres significantly increased the gland mass, where the gland 









Figure 6.6 Coomassie blue staining of SDS-PAGE gels of de-ligated glands 
homogenates some variations in protein contents. All samples showed acinar mucins 
(band 2). However, the injections of LiCl treated salispheres and ROCKi treated salispheres 





Figure 6.7 Histology and mean area size of acinar cells of regenerated glands post 
injection with untreated, LiCl, ROCKi and rapa+LiCl salispheres. Images of H&E 
staining illustrated normal histology of regenerated submandibular glands after injecting with 
salispheres. Acinar cell volume appeared approximately comparable among the four 






Figure 6.8 mTOR status post injections in de-ligated glands. All injections in regenerated 
glands appeared to phosphorylate 4e-bp1. However, ROCKi resulted in the phosphorylation 
of 4e-bp1 and the expression of S6 rp.  
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APPENDIX B 
In Appendix B, a series of experiments using salivary gland tissue homogenates 
were used to illustrate the relationship between band intensity and exposure time, as 
shown in some immunoblots which appeared over exposed. This a supplementary 
section to justify using the ChemiDoc system on western blots. In addition, to 
compare the differences in protein expression between untreated samples and 
experimental samples, in arbitrary units.  
 
The principle of the ChemiDoc imaging system avoids the limitations of x-ray film in 
recording chemiluminescent light, as the exposure time is limited when pixels 
become saturated. (red dots) Five dilutions of normal submandibular glands were 
used for gel electrophoresis and immunoblottting under reducing conditions. Table 
2.2 below shows the concentrations of tissue homogenates:  
 














Figure 2.1 Immunoblots of β-actin band intensities in submandibular gland tissue 
homogenates at different time-points; A) 10 seconds, B) 20 seconds, C) 30 seconds, 
D) 40 seconds, E) 50 seconds and F) 60 seconds. The band intensities increase overtime 




Figure 2.2 Band intensities of β-actin at different time points of five quantities of 
submandibular gland tissue homogenates. Charts represent five concentrations of 
submandibular gland tissue homogenates measured at different time. Band intensities as 
shown increased parallel to time of exposure in all samples (from the highest to the lowest 





The use of five quantities of submandibular glands tissue homogenates illustrated 
the parallel relationship between time of exposure and band intensity.  The band 
intensities have been selected for all experiments around 10 and 30 seconds as 
intensities become saturated after 40 seconds.  
